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ABSTRACT 
 
Factors Moderating the Association between Multiple Rating Sources of Geriatric 
Depression: Self, Informant, and Physician 
 
by 
 
Daniel J. Hatch, Master of Science 
Utah State University, 2011 
 
Major Professor: Dr. Maria C. Norton 
Department: Psychology 
 
 Late-life depression is a major public health concern, associated with poor health 
outcomes, including doubling of dementia risk. Psychiatric evaluation is impractical in 
large epidemiological studies, which instead typically rely on self/informant reports, 
which are subject to various biases (stigma, recall). Few studies have addressed level of 
agreement between sources. This study examined associations between these sources and 
assessed whether subject and informant variables moderated these associations. In a 
population-based study of dementia in Cache County, Utah (2002-5), 1,480 subjects 
completed an in-depth clinical assessment (CA). Major depression was assessed via the 
self-report Patient Health Questionnaire-9 (PHQ-9) and informant-rated Neuropsychiatric 
Inventory (NPI-CA). One hundred forty-eight subjects with cognitive impairment also 
completed a psychiatrist’s examination, including the self-report Geriatric Depression 
Scale (GDS), the informant-rated NPI (NPI-MD), and the physician’s clinical rating 
iv 
 
  
(PCR). Bivariate correlations were modest: NPI-CA versus PHQ-9 (r = .26), NPI-MD 
versus GDS (r = .20), GDS versus PCR (r = .22), NPI-MD versus PCR (r = .45). Kappa 
statistics and logistic regression models indicated that the NPI-CA predicted the PHQ-9 
moderately (  =.08, p <.001; OR = 3.1, 95% CI: 1.5 to 6.1). Results also indicated that 
the GDS did not significantly predict the PCR (κ = .10, p > .05; 95% CI:  0.7 to 11.2) nor 
the NPI-MD (κ =.01, p > .05; 95% CI: 0.6 to 6.3), and that the NPI-MD predicted the 
PCR moderately well (κ = .35, p < .001; OR= 11.1, 95% CI: 2.6 to 48.3). CA-NPI 
predicted the PHQ-9 for cognitively normal subjects (κ =.13, p < .001; OR = 10.1, 95% 
CI: 1.9 to 52.6) but not for subjects with mild impairment (κ =.01, p > .05; 95% CI: 0.4 to 
4.3) nor dementia (κ = .14, p > .05; 95% CI: 0.9 to 7.8). No other variables moderated 
these associations. Results suggest the importance of cognitive assessment when 
measuring late-life depression via self-report. 
(129 pages) 
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 CHAPTER I 
INTRODUCTION    
 Depression is common among the elderly, with prevalence rates among this group 
(defined in most studies as persons over age 65) ranging from 86% to 9.4% for major and 
3.1% to 12.9% for minor depression (Djernes, 2006). This is particularly concerning 
given finding that the proportion of elderly persons in the United States is increasing. For 
instance, the U.S. Census Bureau projected that by the year 2030, one out of five persons 
will be over the age of 65 (U.S. Census Bureau, 2008). Much research has been devoted 
to late-life depression. Late-life depression is associated with increased risk for illnesses 
such as heart disease (Williams et al., 2002), decreased immune functioning (McGuire, 
Kiecolt-Glaser, & Glaser, 2002), and osteoporosis (Robbins et al., 2001), and is 
associated with increased mortality after acute myocardial infarction (Carney et al., 
2003). Several studies, including a review by Jorm (2001), have found that depression 
increases the risk for dementia (Dal Forno et al., 2005; Dotson, Resnick, & Zonderman, 
2008; Fuhrer, Dufouil, & Dartigues, 2003; Hebert et al., 2000; Kessing & Andersen, 
2004; Sachs-Ericsson, Joiner, Plant, & Blazer, 2005; Shim & Yang, 2006; Steffens et al., 
2004), while some have found that it does not increase this risk (Chen, Ganguli, Mulsant, 
& DeKosky, 1999; Dufouil, Fuhrer, Dartigues, & Alperovitch, 1996; Henderson et al., 
1997; Vinkers, Gussekloo, Stek, Westendorp, & Van der Mast, 2004). Quality of life is 
also often impaired in late-life depression sufferers.  In a recent study by Doraiswamy, 
Khan, Donahue, and Richard (2002), recurrent sufferers of late-life major depression, as 
measured by the Hamilton Rating Scale for Depression (HAM-D; Hamilton, 1960) 
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scored worse than a normative sample on five out of eight dimensions of the Medical 
Outcomes Short Form-36 Health Survey (SF-36; Ware, 1993) including general health 
perception, mental health, emotional functioning, social functioning, and vitality. Late-
life depression also may contribute to withdrawal, apathy, lack of vigor (Adams, 2001), 
fatigue, and some types of insomnia (Christensen et al., 1999), and increases the risk of 
suicide (Conwell, Duberstein, & Caine, 2002; Minino, Arias, Kochanek, Murphy, & 
Smith, 2002).  
Before late-life depression can be studied or treated, it has to be accurately 
diagnosed.  However, several factors impede an accurate diagnosis of depression. Older 
adults (and their family members) may consider depressed mood as a normal part of 
aging, especially in the presence of stressful life events or chronic stressors (Allen, 
Walker, Shergill, D’Ath, & Katona, 1998). Elderly users of some medications such as 
antihypertensives may also experience depressed mood as a side effect of the medication 
(Ried, Tueth, Handberg, Kupfer, & Pepine, 2005) and if such side effects were 
anticipated, the depressed mood may likewise be considered normal “background” 
experience and nothing noteworthy and thus, would go unreported.     
 The stigma associated with mental illness may well inhibit an accurate diagnosis, 
especially among the elderly. A study by Allen and colleagues (1998) found that older 
adults were more likely than younger adults to have negative beliefs about depression, 
including the belief that depression mainly affects women and that it is unlikely to affect 
elderly persons. It also found that elderly persons were more likely to report that they 
would approach no one for help if they suffered from depression.   
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Cultural beliefs among the elderly also inhibit accurate diagnosis. A study by 
Switzer, Wittink, Karsch, and Barg (2006) found that when elderly participants were 
asked questions about how one should treat depression, most participants’ (83%) 
responses included themes involving personal responsibility, often using methaphors 
involving effortful movement—“(pull) yourself up by the bootstraps,” “you gotta have 
the willpower to dig yourself out,” “I get up and go out and do something, take care of 
it.” If elderly persons view treatment of depression as primarily or exclusively their own 
responsibility, they may be reluctant to disclose depression to physicians or other 
professionals. The article also noted that most elderly persons were raised in a culture 
where they had to pay up front for medical and other services, due to lack of Medicare 
and Medicaid programs, and lack of health insurance offered as an employee benefit. 
Further, most medical insurance policies have greatly reduced coverage for mental health 
claims, when compared to physical ailments. This not only reduces financial incentive for 
disclosure of depression, but the disparity in coverage may send a subtle message that 
mental health issues are less socially acceptable. This may engender a habit of seeking 
services for only the most urgent conditions.  
Dementia may also lead to an inaccurate diagnosis of late-life depression (Burt & 
Zembar, 1995; Manthorpe & Iliffe, 2006). In clinical practice and in epidemiological 
studies of cognitive impairment, in order to render an accurate diagnosis of depression, 
cognitive impairment needs to be taken into account.  Likewise, when the main objective 
is to render an accurate diagnosis for dementia, clinicians need to consider the presence 
of depression. An accurate assessment of both cognitive status and depression help to 
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determine whether depression is the sole causal factor explaining impairment or whether 
depression is part of the symptom profile of an individual with dementia. However, the 
presence of cognitive impairment may affect depression reporting in some individuals. 
For instance, some studies have found that elderly persons are not aware of their 
depressive mood. This impaired insight seems to be linked to dementia. Several (Ott & 
Fogel, 1992; Ott, Lafleche, Whelihan, & Buongiorno, 1996) but not all (Reed, Jagust, & 
Coulter, 1993) studies have found a link between dementia severity and impaired 
awareness of depression. This impaired awareness of depression may render depression 
reports invalid, unless auxiliary informant report is available. 
However, informant reports which are often used in clinical practice and in 
epidemiological studies, suffer from some of the same confounders. They too may be 
influenced by social stigma, and they too may experience lack of awareness of depressive 
mood. In addition, informant reports can be influenced by the degree to which informants 
are familiar with the subject, which is affected by the type of relationship to the subject, 
the strength of that relationship, and geographic proximity to the subject.  
 Nevertheless, obtaining depression data from multiple sources is often preferable 
to reliance on self-report alone. In epidemiological studies, where feasible, self-reports 
and informant reports are often supplemented by physician evaluations, since physicians 
can rely not only on written assessments but also on their own clinical judgment in 
meeting with the subject.  However, physician evaluations, considered by many to be the 
“gold standard” in assessment of psychiatric conditions, are not economically feasible in 
large-scale epidemiological studies. In such studies where thousands of participants must 
5 
 
  
be evaluated, reliance on either self-report or informant report is common. While either 
source of data alone is subject to the greatest risk of bias, a triangulation approach of 
collecting data from multiple sources—subject and informant(s) may reduce this bias.   
 A small number of studies have addressed the strength of association between 
self-report, informant report, and physician report. For instance, a study by Teri and 
Wagner (1991) revealed that patients had lower depression ratings than caregivers (mean 
patient =5.0 versus mean caregiver = 7.6, t(70) = 4.53, p < .0001, Cohen’s d = 0.38) and 
clinicians (mean patient =5.0 versus mean clinician = 8.2, t[69] = 6.20, p < .0001, 
Cohen’s d = 0.46, respectively), and that caregivers had lower depression ratings than 
clinicians t(67) = 2.19, p <.05, Cohen’s d = 0.09. Few other studies addressed the extent 
to which degree of cognitive impairment of the elderly subject and background factors on 
the informant influence the strength of association.   
  Since physician evaluations of late-life depression are often not feasible in large-
scale epidemiological research, it is important to assess the strength of association 
between subjects, informants, and clinicians, and to identify factors related to the 
strongest association among these sources. Studies that have examined this have found 
that subjects tend to be less likely to report depression than informants and clinicians. 
However, caution is warranted in accepting these conclusions, since these studies are 
sparse, and since they have all relied on clinic-based data, which may be biased toward 
individuals who are more likely to report symptoms.  
  This thesis assessed the association between subject, informant, and clinician 
reports of the subjects’ current depression status, and assessed factors that strengthened 
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that association. Secondary analyses were conducted using data from a large, population-
based epidemiological study of dementia, the Cache County Study on Memory, Health, 
and Aging, in which depression data were available from self-report, informant report, 
and physician examination. Such enhanced understanding of the extent of consistency 
between multiple reports will likely aid future community studies of geriatric depression. 
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CHAPTER II 
LITERATURE REVIEW 
Public Health Significance of Geriatric Depression 
 This chapter reviews the literature regarding rating sources of late-life depression. 
First, I demonstrate the public health impact of late-life depression by reviewing the 
prevalence and incidence rates of late-life depression, and by reviewing the consequences 
of late-life depression. I then discuss how subject characteristics, including cognitive 
status, stigma, beliefs among the elderly, gender, medication side-effects and medical 
comorbidities, and prior depression history can impact the accuracy of subjects’ reports 
of depression. Then, I discuss the use of informants in diagnosing depression, and discuss 
how informant and subject characteristics can affect informant reports of depression. In 
addition, I discuss the use and feasibility of physician ratings of depression. Finally, I 
review studies that have assessed agreement between sources.  
 
Prevalence and Incidence Rates 
Major and minor depression are common among the elderly, with community-
based prevalence rates ranging from 86% to 9.4% and 3.1% to 12.9%, respectively 
(Beekman et al., 1995; Djernes, 2006; Eaton, Kalaydjian, Scharfstein, Mezuk, & Ding, 
2007; Steffens et al., 2000). This is particularly concerning given the increasing 
proportion of elderly persons in the United States. The Administration on Aging (2004) 
predicts that the number of persons aged 65 and older will increase to 39 million by 2010, 
to 53 million by 2020, and to 70 million by the year 2030.   
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Consequences of Geriatric Depression 
 Late-life depression can severely affect quality of life. A study by Doraiswamy 
and colleagues (2002) found that sufferers of late-life major depression reported 
decreased general health perception, mental health, emotional functioning, social 
functioning, and vitality. Late-life sufferers of depression are more likely to experience 
withdrawal, apathy, lack of vigor (Adams, 2001), hopelessness (Christensen et al., 1999), 
weight loss (Morley & Kraenzle, 1994), fatigue, some types of insomnia (Christensen et 
al., 1999), are more likely to report pain, and are more likely to have a low perception of 
their general health (Doraiswamy et al., 2002). Depression can also lead to suicide; 
depression diagnosis is present in 80% of people aged 74 or older who commit suicide 
(Conwell et al., 2002). This is particularly concerning given that the frequency of suicide 
is almost twice as high in the elderly population than in the general population (Minino et 
al., 2002). 
Depression can also complicate cooccurring medical illness. Studies have found 
depression to be a risk factor for mortality after myocardial infarction (Carney et al., 
2003), heart failure (among elderly women; Williams et al., 2002), and decreased 
immune functioning (McGuire et al., 2002). Depression among the elderly is associated 
with low bone-mineral density, a risk factor for osteoporosis (Robbins et al., 2001). In 
addition, depression is associated with poor recovery from myocardial infarction (Ladwig 
& Roll, 1994; Romanelli, Fauerbach, Bush, & Ziegelstein, 2002) and is associated with 
poor recovery from interbody cage lumbar fusion surgery (LaCaille, DeBerard, Masters, 
Colledge, & Bacon, 2005). Several studies, including a review by Jorm (2001), have 
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found that late-life depression leads to dementia (Dal Forno et al., 2005; Kessing & 
Andersen, 2004; Shim & Yang, 2006; Steffens et al., 2004), while other studies found no 
such effect (Chen et al., 1999; Dufouil et al., 1996; Henderson et al., 1997; Vinkers et al., 
2004). 
 
Subject Factors Impacting Accuracy of Depression Diagnosis 
 
Before late-life depression can be studied, it has to be accurately diagnosed. 
However, several factors impede an accurate diagnosis of depression. Cognitive deficits 
ranging from mild cognitive impairment (MCI) to dementia may result in unawareness of 
depression symptoms, confounding the diagnosis of depression (McAvay, Raue, Brown, 
& Bruce, 2005). Additionally, individuals may be reluctant to disclose depression 
symptoms due to perceived negative social stigma, a misperception that depression is a 
normative experience in late life, or if related to medication use, may also not be 
reported. Each of these potential confounders is discussed in the following sections of 
this literature review.  
 
Depression Diagnostic Confounders: 
Cognitive Impairment 
Dementia as a depression diagnostic confounder.  In clinical practice and in 
epidemiological studies of cognitive impairment, in order to render an accurate diagnosis 
of depression, cognitive impairment needs to be taken into account. For example, one 
exclusionary criterion for major depression according to the fourth edition of the 
Diagnostic and Statistical Manual of Mental Disorders (American Psychiatric 
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Association, 1994) is any medical condition that could explain the depressive symptoms 
(e.g., dementia). Likewise, in order to render an accurate diagnosis for cognitive disorder, 
clinicians need to consider the presence of depression. A fair degree of symptom overlap 
can exist between depression and dementia. Nondepressed and depressed dementia 
patients exhibit psychomotor slowing, emotional lability, weight loss, crying spells, 
insomnia, pessimism, inability to verbalize affective state (McGuire et al., 2002), and 
non-demented elderly people with depression tend to have difficulties with concentration, 
speed of mental processing, and executive functioning (Alexopoulos, 2005). An accurate 
assessment of both cognitive status and depression help to determine whether depression 
is the sole causal factor explaining cognitive impairment or whether depression is part of 
the symptom profile of an individual with dementia. 
Mild cognitive impairment affects depression assessment. Level of cognitive 
impairment has some impact on subjects’ ratings of depression. McAvay and colleagues 
(2005) looked at whether agreement between subject and informant ratings of symptom 
domains of depression, as measured by the Structured Clinical Interview for Axis I DSM-
IV Disorders (Spitzer, Gibbon , & Williams, 1995), differed depending on level of 
cognitive impairment, as measured by a score out of 13 points possible of a subset of the 
Mini-Mental State Examination, which measures orientation to time, orientation to place, 
and recall of words. Lower scores on this measure indicate greater impairment. To look at 
agreement between sources, the authors used the Kappa statistic (Fleiss, 1981). This is a 
measure of interrater agreement of categorical data, and differs from traditional interrater 
agreement statistics in that it corrects for chance. Kappa scores of 1 indicate perfect 
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interrater agreement, and kappa scores   0 indicate no agreement other than that 
expected by chance. Landis and Koch (1977) suggested the following strength of 
agreement designations for Kappa values: < 0.0 = poor, 0-.20 = slight, .21 - .40 = fair, 
.41-.60 = moderate, .61-.80 = substantial, .81-1.0 = almost perfect. According to this 
statistic, agreement was lower for cognitive symptoms among subjects with more than 
three errors on the orientation and recall questions (κ = .19 for patients with less than 
three errors and κ = -.10 for patients with more than three errors).  However, agreement 
was not lower among subjects with more than three errors for somatic symptoms (κ = .30 
for patient with < 3 errors, κ = .30 for patients with 3+ errors), psychological symptoms  
(κ = .44 versus κ = .32), and suicidal symptoms (κ = .42 versus κ = .38).  
To assess patterns of disagreement between the informant and subject, the authors 
used the asymmetry index (AI), a log linear model technique that involves examining the 
off-diagonal cell frequencies in order to assess whether informants were more likely to 
report symptoms than subjects. AI scores above 1.0 indicated that the informant was 
more likely to report symptoms, while AI scores below 1.0 indicated that the informant 
was less likely to report symptoms. They found that informants were more likely than 
patients to report psychological symptoms when patients made more than three errors 
(AI = 1.2 for patients with < 3 errors, AI = 1.8 for patients with 3+ errors, p 01. ), and 
informants were less likely than patients to report suicidal symptoms when patients made 
less than three errors (AI = 0.3 for patients with < 3 errors, AI = 1.4 for patients with 3+ 
errors). 
Knauper and Wittchen (1994) conducted a study assessing whether differences in 
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working memory capacity account for changes in self-reported depression. Differences in 
working memory capacity were measured by a listening span task described by Daneman 
and Carpenter (1980). This task assesses ability to keep verbal items in working memory 
while performing memory search, comprehension, and judgment tasks. Self-reported 
depression was assessed using the Composite International Diagnostic Interview (CIDI; 
Wittchen & Semler, 1991), a modified and expanded version of the Diagnostic Interview 
Schedule (DIS; Robins, Helzer, Ratcliff, & Seyfried, 1982). They found a negative 
relationship between working memory capacity and the number of physical symptoms of 
depression endorsed by the subject (r = -.34, df = 61, p  .004). Using a two-step 
hierarchical regression analysis in which the number of physical symptoms of depression 
was the outcome variable, the authors found that working memory capacity remained 
significant after adding age to the model (Age: beta = .18, F(1,61) = 1.82, p .18; 
Working memory: beta = -.27, F(2,60) = 3.99, p .05), suggesting that the effect of 
working memory capacity on the number of physical symptoms of depression reported 
was robust to age. These findings support the conclusion that cognitive impairment may 
increase the number of self-reported physical symptoms of depression. 
 
Depression Diagnostic Confounders:  
Perceived Negative Repercussions  
of Disclosure  
 Elderly persons may be reluctant to disclose depression because they believe that 
doing so may have negative repercussions. A study by Roeloffs and colleagues (2003) 
looked at the perceived negative effect of depression. Participants in this study were 
selected from clinics across several states. Forty-four percent of participants were 
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between the ages of 18 and 41, and 56% of participants were 41 years or older. Subjects 
were considered depressed if they scored positive on a five-item screening test based on 
the World Health Organizations Composite International Diagnostic Interview 2.1, 12 
month version (CIDI-12; Wittchen & Semler, 1991) and had depressive symptoms in the 
past month. The authors asked participants if they thought that disclosure of “a recent 
history of depression” (p. 312) would negatively affect their ability to get a job, to change 
health insurance policies, and to maintain friendships. They also asked them similar items 
about disclosure of HIV, hypertension, and diabetes. A high percentage of participants 
expected disclosure of depression to negatively affect some aspect of their lives. Sixty-
seven percent of participants expected disclosure of depression to negatively affect ability 
to gain employment, 59% expected it to affect their ability to obtain health insurance, and 
24% expected it to negatively affect their friendships.  
In bivariate analyses, older age, lower education, employment, social support, 
diagnosis of major depression, increased number of chronic medical conditions, and 
clinic location (the researchers obtained participants from clinics located in several states) 
were all related to the belief that depression disclosure would impact at least one area of 
life. Factors that were not significant in bivariate analyses included: substance misuse, 
hazardous drinking, and health insurance status. Using a multivariate model that 
controlled for socio-demographic variables and severity of illness, the authors found that 
the younger age group (ages 17-34) was less likely to expect disclosure to negatively 
affect employment than the middle age group (ages 35-59; OR = 0.64, p = .035). The 
oldest age group (60+ years old) did not differ from the middle age group in this area. 
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Age was not related to perceived effect of disclosure on health insurance or friendship. 
Perceived negative effect of disclosure on health insurance and friendship was higher in 
participants with three or more chronic medical conditions (OR = 1.79, p = .30 and 
OR = 1.50, p = .046, respectively). Women were more likely to perceive a negative effect 
of disclosure on jobs than men (OR = 3.70, p = 0.027), but a female gender by social 
support interaction term indicated that women with social support were less likely to 
perceive a negative effect of disclosure on jobs than women without social support 
(OR = 0.70, p = 0.039). These findings suggest that some persons, particularly the 
middle-aged and elderly, females, and those with a greater number of medical conditions, 
are more likely to report depression symptoms because of concerns about employment, 
health care coverage, and friendships. 
The relationship between perceived negative effects of disclosure, utilization 
(mental health specialty visits, primary care visits for emotional reasons, primary care 
medical visits, and total visits) and unmet need were equivocal. Regression models using 
perceived negative effects of disclosure as a predictor and utilization of unmet need as a 
dependent variable and which adjusted for depression severity found perceived negative 
effects of disclosure on employment to be related to less unmet need for mental health 
services (OR = 0.24, p < .01). Perceived negative effects of disclosure on friendship was 
related to more unmet needs for mental health services (OR = 1.51, p = .037), and 
perceived negative effects of disclosure on health insurance was related to more medical 
visits (B = 0.89, p = .02) and more receipt of appropriate treatment (OR = 1.49, p = .03). 
There were no other statistically significant relationships between perceived negative 
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effects of disclosure and unmet needs/utilization variables. These findings suggest that 
perceived negative effects of disclosure have diverse effects on health care utilization.  
 
Depression Diagnostic Confounders:  
Belief That Depression is a “Normal”  
Part of Aging 
In addition to lack of awareness and stigma, older adults (and their family 
members) may even consider depressed mood as a normal part of aging. For instance, a 
study by Farrer, Leach, Griffiths, Christensen, and Jorm (2008) found that among 
participants aged 70 or older, fewer persons (41.5%) identified depression in a vignette 
depicting a 30 year old man or woman with depression than those in other age categories: 
18-24 years (71.7%, z = 4.77, Cohen’s h = .64), 25-39 years (70.8%, z = 5.76, Cohen’s 
h = .61), 40-54 years (67.4%, z = 5.0, Cohen’s h = .53), and 55-69 years (64.9%, z =4.3, 
Cohen’s h = .50).  
Presence of depression may also influence the likelihood of reporting depression, 
although findings conflict as to whether the presence of depression makes a person more 
or less likely to report symptoms. Allen and colleagues (1998) found that older persons 
with depression, as measured by the Geriatric Depression Scale (MD-Self; Yesavage et 
al., 1982), were less likely than older persons without depression to report that they 
would approach anyone (χ2 = 8.7, Fisher’s exact test p < 0.03), or that they would 
approach a spouse (χ2 =5.9, p < 0.03), if suffering from depression. A study by O’Connor, 
Rosewarne, and Bruce (2001) found that severity of depression, as measured by the Scale 
for Depressive Symptoms (SDS; Henderson, Jorm, Mackinnon, & Christensen, 1993) 
which measures dysthymia, depressive episode, and major depressive disorder, was 
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independently and positively related to self-rated likelihood of reporting depression 
symptoms to a general practitioner (β =.143, p < .00005). Past psychiatric contact and 
female gender were also independently and positively related to self-rated likelihood of 
reporting depression symptoms to a general practitioner (β = .589, p < .00005 and 
β = .241, p = .03, respectively). 
 
Depression Diagnostic Confounders:  
Gender 
 Studies have found that depression is more common among females. In a review 
of studies assessing the prevalence of depression among older persons, Djernes and 
colleagues (2006) found that older females were more likely to have depression than 
older males (odd ratios: 3.4 to 1.3).  However, several lines of evidence suggest that this 
increased prevalence may be due in part to reporting artifact. Hinton, Zweifach, Oishi, 
Tang, and Unutzer (2006) found, for example, that older males with major depression or 
dysthymia, as measured by the Structured Clinical Interview for DSM-IV (SCID; Spitzer, 
Williams, Gibbon, & First, 1992), were less likely to seek treatment than older females 
with major depression or dysthymia. In a series of multiple regression models that 
controlled for marital status, minority status, presence of two or more prior depression 
episodes, presence of suicidal thoughts, presence of cognitive impairment (as determined 
by a screening question), depression score, and site from which the participant was 
recruited, the researchers found that men were less likely to use any antidepressant in the 
previous three months (OR = 1.42, p = 0.0038), to receive any depression care in the 
previous three months (OR = 1.43, p = 0.0031), to receive any depression care throughout 
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their lifetime (OR = 1.74, p < 0.0001), or to receive potentially effective depression 
treatment, defined as at least four sessions of psychotherapy or at least two months of 
antidepressant usage (OR = 1.69, p = 0.0002). Older males may avoid treatment because 
they are reluctant to admit that they have depression symptoms.  
 Estimates of gender disparities in depression may also be distorted because of 
different symptom patterns among males and females. For instance, Hinton and 
colleagues (2006) found that depressed older men were less likely than depressed older 
women to report that they felt depressed or down (men: 39% versus women: 47%, χ2 = 
21.24, p < 0.001), that they had lost interest in the things they enjoyed (men: 37% versus 
women: 42%, χ2 = 7.14, p = 0.008), that they felt fatigued (men: 62% versus women: 
67%, χ2 = 7.49, p = 0.008), and that they had appetite problems (men: 34% versus 
women: 41%, χ2 = 14.36, p < 0.001). Men are also more likely than women to commit 
suicide. A study by the Centers for Disease Control and Prevention (Minino et al., 2002) 
found that among persons of all ages suicide rates were four times higher among men 
than among women (18.1 per 100,000 in men versus 4.0 per 100,000 in women). Some 
authors have argued that current depression instruments reflect symptom patterns more 
closely associated with the female gender. If this is so, current depression instruments 
may underestimate depression among males (Möller-Leimkühler, 2002).    
 Hinton and colleagues (2006) also found that men express depression differently. 
In semistructured interviews of primary care physicians, depression care managers (nine 
nurses and two psychologists), and research assistants, respondents expressed a belief 
that men were less likely to express the emotional aspects of depression. For example, 
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one physician said, “Women in general are much more likely to present with mood 
symptoms saying they are feeling depressed or feeling anxious or nervous. I think men in 
general, especially older men, are much less likely to mention those red flag kind of 
words.” Respondents had various explanations for this discrepancy. Some stated that men 
did not express the emotional aspects of depression because they do not recognize them, 
while other respondents stated that they purposefully tried to hide them from others.  
In addition, some respondents stated that men were less willing to accept a 
depression diagnosis. For example, one primary care physician stated, “They [men] just 
do not go with the labels. They’ll say, no I’m not sleeping well, I have aches and pains. It 
seems to be a leap for them to accept depression treatment for that. The men recognize 
the symptoms, but they still do not think it is them.” The study found that this reluctance 
to admit depression may be due to traditional conceptions of masculinity. Some 
respondents described a subgroup of men who believed that men should be self-
sufficient, stoic, and tough. These men may be reluctant to express or report symptoms of 
depression such as worthlessness, helplessness, and sadness for fear of seeming unmanly.   
 
Depression Diagnostic Confounders:  
Medication Side-Effects and  
Medical Comorbidities 
Comorbid medical conditions may also confound the diagnosis of depression 
among the elderly when using self-report or informant report (Alexopoulos, 2005). 
Depression can be a side effect of some medications, including beta-blockers 
(Alexopoulos, 2005; D.C. Steffens, personal communication, March 30, 2009) and some 
steroids (Brown & Suppes, 1998; D.C. Steffens, personal communication, March 30, 
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2009). Depression can also be a side effect of interferon (Zdilar, Franco-Bronson, 
Buchler, Locala, & Younossi, 2000; D.C. Steffens, personal communication, March 30, 
2009), although this drug is rarely used. If such side effects were anticipated, the 
depressed mood may likewise be considered normal ‘background’ experience and 
nothing noteworthy.  
As noted by several authors (Alexopoulos et al., 2002; McAvay et al., 2005) 
elderly patients are more likely to report symptoms of medical illness and to omit 
symptoms of mental illness when communicating with their physicians, which makes a 
depression diagnosis less likely. This is likely to occur in patients with medical 
conditions related to depression. These include vascular conditions such as heart attack 
(Alexopoulos, 2005), stroke (Yamaguchi, Kobayashi, Koide, & Tsunematsu, 1992), 
hypertension (Jonas, Franks, & Ingram, 1997), type II diabetes (Anderson, Freedland, 
Clouse, & Lustman, 2001), and hypercholesterolemia (Van Melle et al., 2006), as well as 
other conditions such as viral infection, endocrinopathy, malignant disease, and 
metabolic disorders (Alexopoulos, 2005). The symptoms of some medical conditions 
mimic the symptoms of depression. For instance, the symptoms of apathetic delirium 
include reduced speech, withdrawal, and nonspecific dysphoria (Armstrong, Cozza, & 
Watanabe, 1997). Some elderly persons deny having depressed mood but report a lack of 
feeling or mood or a lack of interest in normally pleasurable activities. This tendency of 
elderly persons to omit the affective symptoms of depression has been described as 
“depression without sadness” (Gallo & Rabins, 1999).  
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Depression Diagnostic Confounder:  
Prior Depression History 
Depression incidence is higher among persons with a prior history of depression. 
A study by Norton and colleagues  (2006b) found that incidence of major depression per 
1,000 person years, as measured by the Diagnostic Interview Schedule (DIS), was greater 
for participants with a prior minor depressive episode (23.0) than it was for participants 
without a prior minor depressive episode (8.32). A study by Murphy and colleagues 
(2002) was consistent with this finding. They found that the incidence of major 
depression per 1,000 person years, as measured by the DIS, was much higher for 
participants with a prior history of dysthymic disorder (210.5), than it was for participants 
in a reference category (4.0). This relationship is likely due to the chronic nature of 
depression. However, it may also be a reporting artifact; the relationship between 
incidence and prior history may indicate a greater willingness to report symptoms among 
some persons.  
 
Informant-based Report of Geriatric Depression 
 
 Often, collateral informants are also queried about depression symptoms of older 
adults, given that they are typically used as confidantes and provide an important 
additional perspective. In a mixed methods study of current and recent sufferers of late-
life depression, Piercy, Norton, and Cloward (2007) found that older adults’ primary 
source for emotional support for depression was close family members. In fact, most 
expressed reluctance to seek emotional help from or disclose depressive symptoms to 
anyone but close family members. This suggests the need for a more family-systems 
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approach in both clinical practice and epidemiologic studies, in which information about 
the older adult’s depressive symptoms is obtained from both self-report and through 
family members. However, informant reports used in clinical practice and in 
epidemiological studies suffer from some of the same confounders; they too may be 
influenced by perceived social stigma, and they too may experience lack of awareness of 
depressive mood.   
Various types of informants can be seen in the research literature on geriatric 
depression. McAvay and colleagues (2005) used spouses, children-in-law or children, 
siblings, friends, and “other relatives” as informants of depression. In other studies of 
informant reports of depression informants were described simply as “caregivers” (Teri 
& Wagner, 1991). A study by Castle (2005) on informant reports of patient care 
satisfaction used “family members.” Some studies of informant reports of depression 
used employees as informants (Bourgeois, Dijkstra, & Hickey, 2005; McAvay et al., 
2005). A study by Ott and colleagues (1996) on informant reports of memory and 
functional decline also used employees as informants.   
As subjects get older, the availability of the spouse as the informant decreases due 
to mortality. Because of this, researchers often use adult children, friends, and other more 
distant relatives as informants. These informants are often less knowledgeable of the 
subject’s affective state than the spouse. In addition, informant reports of the subject’s 
affective state can be influenced by other factors, such as the number of years the 
informant has known the subject, and frequency of contact with the subject, since these 
factors affect the amount of interaction between the informant and the subject.  
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Clinician Evaluation of Depression 
 
 Because of these limitations, self-reports and informant reports are often 
supplemented in research studies by physician evaluations, since physicians can rely not 
only on written assessments but also on follow-up questioning, observations, and their 
own clinical judgment in meeting with the subject. However, physician evaluations, 
considered by many to be the “gold standard” in assessment of psychiatric conditions, are 
simply not economically feasible in large-scale epidemiological studies. In such studies 
where thousands of participants must be evaluated, reliance on either self-report or 
informant report is common. While either source of data alone is subject to the greatest 
risk of bias, a triangulation approach of collecting data from multiple sources (subject and 
informant) reduces this bias.  
Several instruments can be used to assess late-life depression. The Patient Health 
Questionaire-9 (PHQ-9; Kroenke, Spitzer, & Williams, 2001) is a nine-item depression 
instrument that can be self-administered. This instrument uses a symptom checklist to 
diagnose major depression as well as subthreshold depression, which it calls “other 
depressive disorder.” The Geriatric Depression Scale (Yesavage et al., 1982) is a 30-item 
self-report measure of depression specifically designed for the elderly. Like the PHQ-9, 
the GDS uses a symptom checklist to diagnose depression. Informant report may come 
from an instrument such as the Neuropsychiatric Inventory (NPI; Cummings et al., 1994). 
The NPI is an informant-based assessment and is specifically designed for persons with 
dementia. The NPI uses semi-structured interviews to measure ten behavioral domains, 
including depression/dysphoria. Like the GDS and PHQ-9, the NPI uses a symptom 
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checklist to assess depression. The NPI also asks about the frequency and severity of 
depression symptoms.  
 
Association of Depression Reports between Multiple Sources 
 
There have been very few published studies that have addressed the extent of 
association between self-report, informant report, and clinician reports of geriatric 
depression. Each of these studies and their limitations are summarized below.  
 
Self-Report versus Informant-Report  
of Depression 
 McAvay and colleagues (2005) looked at the association between patient and 
informant reports of depression. Patients in this study were recruited from medical home 
care centers. Mean patient age was 78 years (range 65-100).  In a study of 539 generally 
cognitively normal patients from medical home care, 430 were able to nominate “a 
family member or close friend” (p. 509) to be an informant. Informants in this study 
included spouses (40.6%), children or children-in-law (36.9%), 17 siblings or siblings-in-
law (4.8%), other relatives (5.4%), friends (11.8%), and 2 paid employees (0.6%). Most 
of the informants were female (73%). Patients and informants were interviewed using the 
Structured Clinical Interview for Axis I DSM-IV Disorders (Spitzer et al., 1995). The 
authors postulated that the association between sources of information would depend on 
the type of depression symptomatology, as well as level of cognitive impairment, 
informant age, patient and informant gender, and whether or not the informant had daily 
contact with the patient. Types of depression symptomatology included somatic 
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symptoms (decreased appetite or weight loss, increased appetite or weight gain, 
psychomotor agitation or psychomotor retardation, insomnia or hypersomnia, fatigue or 
loss of energy), cognitive symptoms (indecisiveness or diminished ability to concentrate 
or think), psychological symptoms (diminished interest or pleasure, depressed mood, 
worthlessness, inappropriate guilt), and suicidal symptoms (thoughts of death, suicidal 
ideation). To compute scores for each symptom domain, the authors counted the number 
of symptoms endorsed in each (somatic: 0-3+, cognitive: 0-1, psychological: 0-2+, 
suicidal: 0-1). Cognitive functioning was assessed using a score out of 13 total points 
possible of a subset of the Mini-Mental State Examination which measured orientation to 
time, orientation to place, and recall of words (MMSI; Folstein, Folstein, & McHugh, 
1975).  
In general, agreement was fair or poor in all four depression domains. It was 
found that informants were more likely than patients to report psychological and 
cognitive symptoms (asymmetry index [AI] =1.4, p .001, and AI = 1.7, p  .05, 
respectively; κ = .41 and κ =.09, respectively) and that informants were less likely than 
patients to report suicidal symptoms (AI =.52, p .10, κ =.41). Disagreement was poor for 
the somatic domain (κ =.31, no AI reported) and did not follow a definite pattern.   
Level of cognitive impairment had some impact on agreement. Kappa showed 
mostly agreement. Kappa was lower in the cognitive domain among subjects with more 
errors on the orientation and recall questions (κ = .19 for patients with less than three 
errors and κ = -.10 for patients with more than three errors). However, kappa was not 
lower among subjects with more errors in the somatic (κ = .30 for patient with < 3 errors, 
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κ = .30 for patients with 3+ errors), psychological (κ = .44 for patient with < 3 errors, 
κ = .32 for patients with 3+ errors), and suicidal domains (κ = .42 for patient with < 3 
errors, κ = .38 for patients with 3+ errors). Less agreement was shown in the AI. 
Informants were more likely than patients to report psychological symptoms when 
patients made more than three errors (AI = 1.2 for patients with <3 errors, AI = 1.8 for 
patients with 3+ errors, p 01. ), and were less likely than patients to report suicidal 
symptoms when patients made less than three errors (AI = 0.3 for patients with < 3 
errors, AI = 1.4 for patients with 3+ errors, p 05. ).  
Informant age had some effect on agreement. It did not affect kappa agreement on 
any of the domains. However, the AI showed that agreement was affected by informant 
age. It was found that younger informants (23 to 64 years of age) were more likely than 
older informants (65 to 95 years of age) to report more psychological symptoms than 
patients (AI = 1.6 versus 1.1, respectively), and to report more cognitive symptoms than 
patients (AI = 3.7 versus 0.8, respectively). AI did not vary by age for the somatic and 
suicidal domains. 
Although the researchers found that patient gender, informant gender, and 
frequency of contact with the patient affected agreement, they were unable to make any 
certain conclusions about the effects of these factors because of the high correlations 
between them. For instance, the authors found that 90% of male patients used female 
informants, whereas only 59% of female patients had female informants. Because of this, 
the authors could not conclude whether differences in AI among male and female patients 
were due to patient gender or to informant gender.     
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Snow and colleagues (2005) found that discrepancy between patient reports and 
informant and clinician reports of depression were not due to dementia per se, but to 
patient awareness of dementia deficits. In this study, researchers conducted two 
hierarchical regression models. In one model, severity of cognitive impairment (as 
measured by the cognitive subscale of the Alzheimer’s Disease Assessment Scale), 
physical illness, functional status, caregiver burden, clinician reports of depression 
(Cornell Scale for Depression in Dementia), and awareness of dementia were entered as 
predictors, and patient/informant depression discrepancy scores (difference between the 
summed informant rated Geriatric Depression Scale scores and the summed patient-rated 
GDS scores) were entered as the dependent variable. Informants in this study were 
relatives, friends, and caregivers and had at least four hours of contact a week with the 
patient each week. Although the authors did not include gender in their analyses, it 
appeared to be an important factor. Demographic information reported in the study 
revealed that females may have been less likely to be diagnosed with only depression; 
whereas the control, dementia only, and depression and dementia groups were 52%, 42%, 
and 45% female, respectively, the depression only group was only 23% female. 
The authors found that among patients with and without a previous diagnosis of 
dementia, awareness of dementia was the only factor that predicted the discrepancy 
between patient and informant depression scores (dementia sample: F[7,65] = 3.63, 
informant-patient DDS discrepancy β = 0.60, p < .005; nondementia sample: F[7,54] = 
4.08, informant-patient DDS discrepancy β = 0.57, p <.001). A similar model used 
severity of cognitive impairment, physical illness, functional status, informant-rated GDS 
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scores, and awareness of dementia (as measured by the patient-clinician discrepancy 
score on the DDS) as predictors and patient-clinician depression discrepancy scores 
(difference between the summed clinician-rated Cornell Scale for Depression in 
Dementia scores and the summed patient-rated GDS scores) as the dependent variable. 
Findings were similar to those in the first model; among patients with a previous 
diagnosis of dementia, awareness of dementia deficits was the only factor that predicted 
the discrepancy between patient and clinician depression scores, F(6,54) = 2.92, 
informant-patient DDS discrepancy β = 0.32, p < .05.  
The authors also found, in turn, that awareness of dementia deficits depends on 
dementia diagnosis. Patient-informant discrepancies on the DDS indicated that patients 
previously diagnosed as having dementia or as having both dementia and depression were 
significantly more likely to report fewer dementia symptoms than were controls or 
patients previously diagnosed with depression only (mean discrepancies  SD: 
controls; -0.54  0.56, depression only; -0.54  0.81, dementia only; 0.43  0.99, 
depression and dementia; 0.26  1.33; scores above 0 indicated that the informant rated 
depression higher, while scores below 0 indicated that the patient rated depression higher; 
controls versus dementia only: p < .01, controls versus depression and dementia: p < .05, 
depression only versus dementia only: p < .01, depression only versus depression and 
dementia: p < .05). Patient-clinician discrepancies on the DDS revealed similar findings. 
Patients previously diagnosed as having dementia or having both dementia and 
depression were significantly more likely to report fewer dementia symptoms than were 
patients previously diagnosed with only depression (mean discrepancies: depression only; 
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-1.23, dementia only; 0.51, depression and dementia; 0.08; depression only versus 
dementia only: p < .001, depression only versus depression and dementia: p < .01). 
 
Self-Report Versus Physician Rating  
of Depression 
Ott and Fogel (1992) looked at the association between self-report, caregiver 
report, and clinician report of depression. In this study the authors used the Geriatric 
Depression Scale (Yesavage et al., 1982) to assess self-reports of depression, the HAM-D 
(Hamilton, 1960) to measure caregiver reports of depression, and the Cornell Depression 
Scale for Depression in Dementia (Alexopoulos, Abrams, Young, & Shamoian, 1988) to 
measure clinician reports of depression. The study also looked at how awareness of 
dementia affected the strength of association between rating sources. Researchers 
assessed impaired insight of dementia using a self-report questionnaire that asked if 
patients had (a) awareness of the situation, (i.e., reason for the office visit), (b) awareness 
of memory impairment, (c) awareness of impairment in activities of daily living, and (d) 
awareness of progression of deficit. Each question was scored on a 0-2 scale, with a total 
possible range of 0-8. Higher scores on this measure indicated less insight. Dementia 
severity was also assessed in order to ascertain its effect on the strength of association. 
Three scales were used for this: The Clinical Dementia Rating Scale (Morris, 1993) 
possible range 0-3, higher scores indicate greater impairment), the MMSE (range 0-30, 
lower scores indicate greater impairment), and the brief Orientation-Memory-
Concentration Test (Katzman et al., 1983) possible range 0-28, higher scores indicate 
greater impairment). 41 of the 50 participants in the study obtained MMSE scores 26 . 
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Mean Clinical Dementia Rating Scale score was 1.1 (SD = 0.7), mean MMSE score was 
20.3 (SD = 7.5), and mean OMC score was 13.7 (SD = 8.2), indicating a range of 
cognitive impairment. Of the 50 participants, 23 were male, and 27 were female. Since 
caregiver depression could affect ratings of patient depression, researchers also 
administered the GDS to caregivers.   
Researchers found that caregiver depression did not affect ratings of patient 
depression and that dementia and impaired insight of dementia decreased the association 
between patient and clinician reports of patient depression. GDS scores of caregiver 
depression correlated poorly with clinician-rated COR scores and caregiver-rated HAM-
D scores (HAM-D: r = 0.202, p = 0.245; COR: r = 0.266, p = 0.123), indicating that 
caregiver depression did not affect caregiver ratings of patient depression. The HAM-D 
and COR correlated well (r = 0.92, p < 0.0005), indicating congruence between caregiver 
and clinician reports. Insight and cognitive impairment were strongly related (insight and 
MMSE: r = -0.67, p < 0.005; insight and OMC; r = 0.64, p < 0.005). GDS and COR 
scores were only moderately associated (r = 0.40, p = .0004). This correlation was even 
lower among patients with MMSE scores less than 22 and insight scores greater than two 
(r = 0.15, p value not reported). In addition, a multivariate analysis using MMSE score, 
clinical dementia rating, diagnosis of AD, insight score, history of depression, age, sex, 
and education as predictor variables revealed clinical dementia ratings and insight scores 
to be the only significant predictors of GDS-COR discrepancy scores (clinical dementia 
ratings: coefficient = -3.12, t = -2.38, p = 0.02; insight score: coefficient = -1.39, t 
= -4.25, p < 0.0005). MMSE scores approached significance (coefficient = -0.16, 
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t = -1.21, p = 0.23).  
 
Self- Versus Informant- Versus  
Clinician Ratings  
Teri and Wagner looked at the association between AD patients, informants, and 
clinicians (Teri & Wagner, 1991). To do this they obtained three separate total scores on 
the HAM-D (Hamilton, 1960); one using self-report information only, one using 
caregiver information only, and one in which the geriatricians used both the self-report 
and caregiver report as well as their own behavioral observations to come up with a 
score. The geriatrician used this score and DSM-III criteria to diagnose depression. All 
75 patients in the study had DSM III-R diagnosis for primary degenerative dementia of 
the Alzheimer’s type (AD). Participants in this study were predominantly female (68%). 
Caregivers consisted of spouses (51%), daughters (27%), sons (13%), and others (9%). 
The authors found that Alzheimer’s patients diagnosed as depressed according to the 
clinical diagnosis reported less insomnia, change in interests, psychic anxiety, and 
somatic energy change than did the caregiver or the clinician, and that they reported less 
depressed mood, suicidal feelings, and somatic anxiety than the caregiver. Alzheimer’s 
patients without depression exhibited similar findings; they reported less depressed mood 
and less change in interests than the caregiver or the clinician, and they reported less 
agitation, psychic anxiety, and somatic energy change than the clinician. It also found 
that caregivers reported less agitation and somatic energy change than did the physician. 
In addition, the study found that severity of dementia did not affect rating. Few other 
studies addressed the extent to which degree of cognitive impairment of the elderly 
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subject and background factors on the informant influence the association between 
multiple sources.  
 
Conclusion 
 
Depression among the elderly is a major public health concern. Accurate 
diagnosis of depression is needed in clinical practice and in epidemiological studies of 
cognitive impairment. Research literature reveals that, in general, subjects are less likely 
to report depression than other sources. Several factors contribute to this. Some studies 
have found that cognitive impairment affects patient self-reports of depression, with 
patients with cognitive impairment reporting less depression than informants or 
physicians. Other studies have found that social stigma inhibits patients from fully 
disclosing depression. Social stigma may affect informant reports of depression as well. 
Presence of depression itself tends to decrease reports of depression. Since depression is a 
side effect of some medications and medical conditions, patients and informants may 
view depression as “normal” and not noteworthy. The literature on the accuracy of 
informant reports is mixed. Some evidence suggests that type of informant and informant 
age affects depression reports. However, very few studies have explored how informant 
factors affect depression reports. Although physician evaluations are free of much of the 
reporting bias inherent in self-reports or informant reports, they are often not feasible in 
epidemiological studies.  
 The preceding findings lead to the following research questions. 
1.  What is the strength of association between subject self-report, informant 
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report, and physician reports of major depression? 
2. Is the association between subject self-report and physician report of major 
depression, and the association between subject self-report and informant report of major 
depression, affected by subject characteristics including: subject age and gender, degree 
of cognitive impairment, medical comorbidities, use of medications with depressogenic 
side effects, or prior history of major depression? 
3.  Is the association between informant report and subject self-report of major 
depression, and the association between informant report and physician report of major 
depression, affected by informant characteristics including: informant age, informant 
relation to subject, how long the informant has known the subject, or by frequency of 
contact with the subject?  
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CHAPTER III 
METHODS 
 
This chapter describes an extant dataset made available for this thesis project.  
Subject selection, procedures, measurement and analyses relating to stated research 
questions will also be described, after first providing a brief overview of the original 
study. 
 
Overview of the Cache County Study on Memory 
 
Health and Aging  
 
The Cache County Study on Memory Health and Aging (CCSMHA) is a large, 
population-based epidemiological study of dementia. Funded continuously since 1994 by 
the National Institute on Aging (R01-AG-11380), it was designed to study prevalence 
and incidence of Alzheimer’s disease (AD) and other dementias, and the influence of 
genetic and environmental factors, and their interactions, on disease risk. This was 
accomplished by a large-scale data collection effort at each of four triennial “waves” of 
ascertainment of dementia and depression (an important potential confounder when 
diagnosing dementia).  Data sources included self-report, informant-report, and physician 
assessment. Because all of the depression measures required for this thesis project were 
not collected until Waves 3 and 4, data derive from these two study waves, with the 
exception being depression data from Waves 1 and 2 used only to establish prior 
depression history.   
 
34 
 
  
Subjects 
 The CCSMHA is a population-based study that sought to enroll 100% of eligible 
residents of Cache County aged 65 years or older as of January 1, 1995. The final sample 
for this thesis project included 1,481 subjects who completed a clinical assessment 
(hereafter referred to as the “CA visit”) in either Wave 3 or 4, and 148 subjects who 
completed a physician assessment (hereafter referred to as the “MD visit”) in either Wave 
3 or 4.  What follows is a description of the final derivation of this sample, beginning 
from the original eligible pool of individuals. 
The original list of eligible individuals came from Medicare enrollee lists from the 
Health Care Financing Administration (HCFA) of those with permanent residence in 
Cache County, Utah, who were aged 65 years or older as of January 1, 1995. A small 
number were recruited from other sources such as local publicity efforts. Eligible 
participants totaled 5,677 when fieldwork began in April 1995. Total number of 
participants enrolled in the study was 5,092.  The high participation rate of 90% greatly 
reduced non-response bias (Norton, Breitner, Welsh, & Wyse, 1994), which would tend 
to underestimate prevalence and incidence rates of both dementia and depression, owing 
to the higher probability of those who refuse participation to have greater cognitive 
impairment, to be older, and have less education, and to be depressed, all of which factors 
being related to dementia risk (Welsh-Bohmer et al., 2006).   
Cache County was selected for this study for several reasons. It was reported to 
have the highest longevity rate in the U.S. (Murray, Michaud, & McKenna, 1998). Based 
on 1990 Census data, women’s life expectancy was 88.1 years (compared to U.S. rate of 
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78.5 years) and men’s life expectancy was 85.7 years (compared to U.S. rate of 71.5 
years). Greater longevity substantially improves a study’s ability to examine prevalence 
and incidence rates of conditions that afflict those in older age groups such as dementia. 
These reduced mortality rates are in part due to a religious denomination—The Church of 
Jesus Christ of Latter-day Saints—which proscribes alcohol and tobacco use. Of the local 
population of older adults, 91% are members of this religion (Norton et al., 2006a). The 
population of Cache County is associated with reduced rates of alcohol and tobacco use, 
resulting in reduced rates of several common cancers, hypertensive and atherosclerotic 
cardiovascular disease, and lower rates of mortality before age 85. These characteristics 
also help simplify the differential diagnosis of dementia. This population is also 
associated with larger families, which provides more opportunities for informant 
interviews. Higher rates of education found in Cache County also simplified the 
diagnosis of dementia; since subjects typically started higher on cognitive screening 
instruments, declines over time could be more readily detected. In addition, Cache 
County has low rates of in and out migration, which leads to greater participant 
consistency. This consistency is of great benefit in longitudinal studies.  
Of the population of persons 65 years or older identified in Cache County, 542 
refused interviewing, 26 were deceased, and 17 could not be located, leaving 5,092 
participants. Of these, 371 were identified in Wave 1 as having dementia, leaving 4,721 
persons who were eligible for the Wave 2. Of these 4,721 persons, 594 were deceased, 
159 moved away, 546 refused interviewing, and 15 could not be located, leaving 3,407 
persons who participated in Wave 2. Wave 2 identified 204 of these persons as having 
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dementia, leaving 3,203 eligible for Wave 3.  
In Wave 3, 2,324 persons participated in the screening assessment, while 97 
persons were deceased, 75 had moved away, 354 refused, 25 persons could not be 
located. The researchers selected participants for the CA visit if at the screening 
assessment the participants were 85 years of age or older, if they had screened positive 
(score of 90 or lower) on the Modified Mini-Mental State Examination (3MS; Teng & 
Chui, 1987), or if they were selected to be part of a designated control panel (details 
provided below).  Of the 2,324 completing screening in Wave 3, 1,593 were selected for 
the CA (68.5%), and of these 1,224 (76.8%) completed the CA, while 74 were deceased, 
24 had moved or were not located, and 271 refused. Participants that were given a 
provisional diagnosis of dementia or “mild/ambiguous” impairment (subsyndromal AD) 
at the case staffing review of the CA visit were selected for the physician evaluation. Of 
the 1,229 completing the CA visit, 423 participants were selected for the MD visit 
(34.6%), and of these, 357 (84.4%) completed the MD visit27 were deceased, 4 had 
moved or could not be located, and 35 refused.  
To ensure independence of observations, only one set of data was used for each 
subject.  If a subject completed the CA and/or MD visit at both Waves 3 and 4, only the 
data from Wave 3 were used (this protocol is described in more detail in Appendix B, 
along with analyses to determine similarity across several demographic measures 
between subjects whose data came from Wave 3 versus Wave 4). As a result of this 
protocol, this study utilized data from the 1,229 persons who participated in the Wave 3 
CA visit and an additional 252 who did not participate in Wave 3 CA visit but did 
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participate in Wave 4 CA visit (total with data from the CA is n = 1,481). In analyses of 
MD visit data, this study utilized data from 124 persons who completed Wave 3 MD visit 
measures and an additional 24 persons who completed the measures at the Wave 4 MD 
visit. 
 
Procedures 
Of primary interest are procedures involved in the collection of depression data 
analyzed in the present work.  However, the sample for this thesis project was comprised 
of the subset of participants who completed the more in-depth clinical data gathering 
portion of the CCSMHA.  Therefore, what follows next is a detailed description of 
procedures employed to determine this final sample, including procedures for the CA and 
MD visits where depression data were gathered. 
The CCSMHA study included four ascertainment “waves,” spaced approximately 
3-4 years apart. The first wave was designed to identify prevalent cases of dementia and 
later waves to identify incident cases. At each wave, participants completed a three-stage 
dementia screening protocol, which consisted of a cognitive screening, a clinical 
assessment (CA visit), and a physician evaluation. Ascertainment protocol was modified 
in Waves 3 and 4. Given that these are the waves from which data was utilized for this 
thesis, protocol for these waves are described here. 
In the first stage, researchers conducted screening interviews to collect both 
cognitive data and information on interval putative risk factors. Cognitive screening 
consisted of the 3MS (Teng & Chui, 1987). The 3MS is a 100-point adaptation of the 
Mini-Mental State examination (MMSE; Folstein et al., 1975) that increases the 
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instrument’s floor and ceiling. Researchers further adapted the 3MS for epidemiological 
studies (Tschanz et al., 2002), including alternate versions of the test that included two 
new word list recall tasks in addition to the original tasks. Informants (typically spouses 
or other family members) were used to collect risk-factor interview data if the subject (a) 
could not complete the 3MS, (b) scored below 15 out of 20 on a set of orientation 
questions asked at the beginning of the interview, (c) scored below 60 on the 3MS, or (d) 
was for any other reason deemed by the clinical judgment of the interviewer as 
unreliable. In all other cases, subjects gave their own risk factor interview data, including 
information about depression using a modified version (Steffens et al., 2000) of the 
Diagnostic Interview Schedule’s Depression Scale (DIS; Robins, Helzer, Croughan, & 
Ratcliff, 1981). Informants were given the Informant Questionnaire for Cognitive Decline 
in the Elderly (IQCODE; Jorm, 1994). This instrument assessed the extent to which the 
subject’s cognitive abilities had declined over the preceding 4-year and 10-year intervals. 
Higher scores on this measure indicate greater impairment. Informants were also asked 
the same set of risk factor questions, including a third-person version of the depression 
interview.  
 Participants with a positive cognitive screening, defined as a score less than or 
equal to  90 points out of 100 on the 3MS (adjusted for education and sensory 
impairments) or an IQCODE composite score greater than or equal to 3.27, were selected 
for CA visit. Also selected for CA were members of a designated control panel initially 
selected in Wave 1 (Breitner et al., 1999), which was replenished in Wave 3 with 
additional random sampling to replace members lost to attrition. This designated control 
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panel was randomly stratified for age, gender, and APOE genotype, weighted to yield a 
2:1 ratio of controls to persons with a positive cognitive screening, except for the 
youngest two strata (65-69 and 70-74 years) with zero or one e4 allele at APOE for 
whom a 4:1 ratio was used. In addition, all participants 85 years of age and older were 
selected for the CA visit. Thus, a substantial portion of those completing the CA visit 
were not selected due to positive screening results. Consequently, the final sample of CA 
visit participants is a more heterogeneous mix of subjects who were cognitively normal, 
had mild cognitive impairment, or had dementia.  
 The CA visit included a brief neurological exam, a clinical history from an 
informant (typically spouse or adult child of the subject), an informant-based 
Neuropsychiatric Inventory, the Patient Health Questionnaire-9 (PHQ-CA), and a battery 
of neuropsychological testing, administered by a trained psychometrician. A board 
certified geriatric psychiatrist and neuropsychologist reviewed the testing from the CA 
visit with the examiners in “case staffing” reviews. After review they assigned 
participants to working diagnoses of dementia (according to DSM-III-R criteria), 
vascular dementia (according to NINDS-AIREN criteria; Roman et al., 1993), AD, 
probable AD, possible AD (according to NINCDS-ADRDA criteria; McKhann et al., 
1984)  or other classifications, such as dementia of unknown etiology, demented-not AD, 
mild/ambiguous (not meeting criteria for dementia, with suspected prodromal AD), or 
other (cognitive symptoms dissimilar from prodromal AD, such as a stroke or 
schizophrenia), and noncase. 
 Only those subjects with a provisional diagnosis of dementia or prodromal 
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Alzheimer’s disease were selected for the physician evaluation. Physicians rendered a 
new working cognitive diagnosis (blinded to the initial diagnosis rendered at the CA case 
staffing meeting). This diagnosis matched the CA case staffing diagnosis for 167 of the 
participants (65%). Discrepancies were generally minor for the other participants (e.g., 
“possible AD” versus “probable AD”). A final diagnosis was obtained after all these 
procedures by consensus of an expert panel of specialists. One or more board certified 
geriatric psychiatrists, neurologists, neuropsychologists, and neuroscientists reviewed all 
information and assigned participants a final diagnosis from a list of 30 differential 
diagnostic categories.   
 Use of human subjects and all procedures employed were approved by the 
Institutional Review Boards of Duke University Medical Center, the Johns Hopkins 
Bloomberg School of Public Health, and Utah State University. Written informed consent 
was obtained prior to every interview. 
 
Measurement Scales 
Of all the measures collected on study participants at the screening visit, the CA 
visit and the MD visit, only those pertaining to assessment of depression are included in 
the present work. Each is described in more detail below, including psychometric 
properties.   
The Diagnostic Interview Schedule –Depression Scale (DIS; Robins et al., 1981) 
was completed at the screening visit of each wave, and was used in the present work to 
derive a “prior major depression history” subject characteristic variable (coded as 
positive/negative report of major depression, up to and including Wave 2). No other 
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depression measure was collected at the screening visit, so this visit does not contribute 
depression data from multiple sources, the focus of this project.   
The DIS assesses a variety of psychological disorders. Both clinicians and lay 
interviewers can administer this measure. The DIS yields lifetime and recent diagnoses, 
as well as onset of recent diagnoses (occurred in last 2 weeks, last month, last 6 months, 
or last year). To ascertain whether lay interviewers could reliability administer the DIS in 
the place of clinicians, Robins et al. assessed agreement between lay interviewer and 
psychiatrists on lifetime diagnosis (Robins et al., 1981). Overall, Kappa statistics for 
showed good agreement (κ = .63). Overall sensitivity and specificity were also good 
(80% and 84%, respectively), as was sensitivity for current patients (sensitivity = 79% 
and specificity = 81%) and former patients (sensitivity = 82% and specificity = 67%).  
The Cache County study modified the DIS by including three “gateway” 
questions asking whether the subject had experienced two or more consecutive weeks of 
sadness, anhedonia (inability to experience pleasure from life events that are normally 
pleasurable), or irritability. If respondents endorsed at least one of these three symptoms 
then interviewers asked DIS questions dealing with specific symptoms, including appetite 
or weight change, sleep or concentration difficulties, guilt, restlessness, diminished 
energy level, or suicidal ideation. Interviewers also asked for year, month, and symptoms 
of any depressive episodes that had happened during the preceding wave interval. 
Diagnosis of major depression was assigned following Blazer, Hughes, and George 
(1987), when subject endorsed five or more DIS symptoms (one of which being sadness 
or loss of interest).  
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Patient Health Questionnaire (PHQ-9) is the 9-item depression module of the 
PHQ, a multi-diagnostic instrument which itself is a brief form of the Primary Care 
Evaluation of Mental Disorders (PRIME-MD; Spitzer, Kroenke, & Williams, 1999) 
scale. In the CCSMHA, the PHQ-9 was self-administered. Major depressive disorder is 
characterized by the instrument as five or more of the nine depressive symptoms for at 
least “more than half the days” in the past 2 weeks, with one of the symptoms being 
depressed mood or anhedonia. Each of the nine DSM-IV criteria is scored on a “0” (not 
at all) to “3” (nearly every day) severity scale, resulting in a total score that can range 
from 0 to 27 points. Scores of 5, 10, 15, and 20 on the PHQ-9 indicate mild, moderate, 
moderately severe, and severe depression, respectively. Subjects exhibiting any 
symptoms answer a question about the functional impact of the disorder.  
The PHQ-9 has demonstrated adequate construct validity (Kroenke et al., 2001). 
PHQ-9 scores were compared with clinician diagnoses of depression, where the clinicians 
utilized the Structured Clinical Interview for DSM-III-R (Spitzer et al., 1992) and 
diagnostic questions from the PRIME-MD (Spitzer et al., 1999) in reaching diagnoses. 
Kroenke and colleagues found that 93% of participants diagnosed as non-depressed by 
the clinician had scores lower than 10 on the PHQ-9, and 88% of participants diagnosed 
as having major depression by the clinician had scores of 10 or greater on the PHQ-9. 
The PHQ-9 was collected at the CA and the cutoff (> 10) was used in the present study to 
indicate major depression. For my analyses, I used only participants that had responded 
to most of the items on this measure (at least five out of the nine items). If these subjects 
had any missing responses, I added to the total score the mean of the non-missing 
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responses for each item that was missing. This method is described in further detail in 
Appendix B.  
Neuropsychiatric Inventory (NPI; Cummings et al., 1994) uses semi-structured 
interviews to measure ten behavioral domains, with depression/dysphoria being the only 
domain examined for this thesis. Informants are given a gateway question, in which they 
are asked if the subject has seemed sad or depressed in the previous four weeks. If the 
answer is affirmative, 15 subquestions are asked. After asking the subquestions, the 
interviewer asks questions about the frequency of symptoms, coded as: 1 = occasionally, 
less than once per week; 2 = often, about once per week; 3 = frequently, several times per 
week but less than every day; 4 = very frequently, once or more per day or continuously. 
Severity is coded as: 1 = mild, 2 = moderate, 3 = severe.   Frequency and severity scores 
are multiplied together to yield the NPI raw depression score that can range from 0-12 
(Steinberg et al., 2004). The NPI can be administered by a variety of professionals. The 
CCSMHA collected the NPI at the CA via research nurse and at the physician evaluation 
by the geropsychiatrist, using identical scoring protocols.  
 The NPI was found to have good content validity, construct validity, and 
reliability (Cummings et al., 1994). A panel of 10 geriatric psychiatry experts rated NPI 
items on how well they represented the essential nature of the behavior. Mean rating was 
1.2 (1 = good, 4 = poor) for the depression/dysphoria screening question and 1.3 for the 
depression/dysphoria subsections. Construct validity was also good; Spearman 
correlations comparing frequency, severity, and frequency x severity depression/ 
dysphoria scores with the “affective disturbances” subscale score of the Behavior 
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Pathology in Alzheimer’s Disease Rating Scale (BEHAVE-AD; Reisberg et al., 1987) 
were 0.54, 0.47, and 0.33, respectively. Internal consistency was adequate (Cronbach’s 
alpha = 0.88). Only 22% of the items were correlated, demonstrating adequate item 
independence. Inter-rater reliability was 97.9% for both frequency and severity of 
depression/dysphoria. Test-retest reliability was also good; coefficients were 0.79 and 
0.84 for frequency and severity, respectively. Following Schneider and colleagues 
(2001), I used a cutoff of 4  to indicate major depression. For my analyses, I used only 
participants that had a non-missing response to the gateway question. No participants at 
the MD visit, and less than 1% of participants at the CA visit were missing responses to 
this question.   
Geriatric Depression Scale (GDS; Yesavage et al., 1982) is specially designed for 
the elderly. For this measure, subjects respond yes or no to each of its 30 items related to 
current depressive symptoms. In 20 of the questions a “yes” response indicates 
depression, while in the other 10 questions a “no” response indicates depression.  One 
point is given for each item indicating depression, yielding a possible range of 0-30 
points. Because researchers began collecting data on this measure part way through the 
Wave 3 MD visit, not all persons that participated in this visit were given this measure.  
Yesavage and colleagues (1982) confirmed the validity and reliability of the GDS. 
Construct validity was demonstrated in that this measure correlated well with other 
depression measures (HAM-D): r = .83, and Zung Self-Rating Depression Scale (SDS): r 
= .84], and was further demonstrated in that mean GDS scores were found to be 
increasingly greater in participants characterized as normal, mildly depressed, and 
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severely depressed according to research diagnostic criteria (RDC; Spitzer, Endicott, & 
Robins, 1978). In addition, the authors found the GDS to be reliable. Median correlation 
of items on the GDS with its total score (r =.56) was comparable to that of other 
depression measures (HAM-D: r =.44, and SDS: r =.56]. Mean correlation among all 
GDS items (r =.36) was comparable to mean correlation among all HRS-D items (r =.25) 
and among all SDS items (r =.34). Cronbach’s alpha for the GDS was high (r =.94), as 
was split-half reliability (r =.94), and test-retest reliability (r =.85).   
 The present study used a GDS cutoff score of 10 to indicate major depression. 
A study by Lyness and Noel (1997) found that this cutoff achieved a sensitivity of 100% 
and a specificity of 84% when compared with the Structured Clinical Interview for the 
DSM III-R (Spitzer et al., 1992). For my analyses, one participant was missing responses 
on 27 of the 30 items, and so was removed. The remaining participants were missing no 
more than 3 of the 30 items.  
 Physician’s Clinical Rating of Depression was also completed during the in-home 
physician evaluation. Because researchers began collecting data on this measure part way 
through the Wave 3 physician evaluation, not all persons that participated in this visit 
were given this measure. This assessment was conducted by geriatric psychiatrists and 
internal medicine physicians with a specialty in geriatric psychiatry. Assessment protocol 
(see Appendix A) given to physicians stated that they could review the most current NPI 
and the GDS from the MD visit, and also that they could gather information from 
subjects during the visit. To aid diagnosis, the protocol also included a list of major 
depressive symptoms and guidelines on diagnosing minor depressive disorder, bipolar 
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disorder, and mood disorder not otherwise specified (NOS). The protocol instructed 
physicians to classify participants into one of five categories: no current depression, 
current major depressive episode, current minor depressive episode, mood disorder NOS, 
and bipolar disorder. The present study categorized participants as to whether the 
physician rated them to have major depression. Acknowledging that this physician 
evaluation did not include a full psychiatric evaluation for depression, the diagnoses 
rendered represent the physicians’ best “clinical impression” of the subject’s current 
depressive state, for the purpose of assigning subjects to “working research diagnoses.”  
Summary of depression measures. Table 1 lists the depression measures that 
were compared. At the CA, the strength of association was evaluated between the PHQ-9 
and the NPI. This comparison had a sample size of 1,481 subjects. At the MD visit, the 
following associations were evaluated: the GDS versus the NPI, the GDS versus the 
Physician’s Clinical Rating of depression, and the NPI versus the Physician’s Clinical 
Rating of depression.  There were 136 cases used for these comparisons. To facilitate the 
reporting of findings, I will hereafter refer to the PHQ-9 and the NPI from the CA visit as 
the “CA-Self” and the “CA-Informant,” respectively, and to the GDS, the NPI from the 
MD visit, and the Physician’s Clinical Rating of depression as the “MD-Self,” the “MD-
Informant,” and the “MD-Doc,” respectively. Table 2 reports the distribution of each 
depression measure as a continuous variable. 
Subject characteristics. Subject gender was noted at the initial interview and age 
was recorded at each interview. To define subject cognitive status, the final expert- 
consensed diagnosis from the CA was used, coded into the trichotomy of: noncase, mild/ 
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Table 1 
Depression Measures 
  
CA (n = 1,481) 
──────────  
MD (n = 148) 
────────── 
Report type Instrument Major Dep. Criteria Instrument Major Dep. Criteria 
Self-report CA-Self  ≥ 5 MD-self ≥ 10 
Informant report CA-Informant ≥ 4 MD-informant ≥ 4 
Clinician report N/A N/A MD-doc a 0-1 
 
a MD-Doc = Physician’s Clinical Rating 
 
 
Table 2 
Distribution of Depression Measures 
Report type Scale Min Max Mean  SD 
CA-Selfa 0-27 0 23 3.3 3.9 
CA-Informantb 0-12 0 12 0.4 1.4 
MD-Self c 0-30 0 19 6.7 4 
MD-Informant 0-12 0 12 1.3 2.6 
 
a CA-Self =Patient Health Questionaire-9, 
b CA/MD-Informant= Neuropsychiatric Inventory from 
c CA or MD visit, MD-Self = Geriatric Depression Scale, 
 
 
other cognitive impairment, and dementia, for analyses of CA visit data, but coded into 
only the latter two categories for analyses of MD visit data (since noncases did not 
complete this visit). Prior depression history was dichotomized into “major depression” 
versus “no major depression” spanning the subjects lifetime from birth through the Wave 
2 screening visit.   
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 Data on medical conditions and use of medications with depressogenic side 
effects were also available. These medications included interferon, and medications from 
the following classifications: beta blockers (e.g., atenalol, propranolol, metoprolol are 
some generic names; Physician’s Desk Reference, 2010) and steroids (e.g., prednisone; 
(Brown, Vera, Frol, Woolston, & Johnson, 2007). Medication information was recorded 
at the CA visit, and was updated by the physician at the MD visit. Information on medical 
conditions was collected at each of the screening visits. Because many subjects had at 
least one medical condition, subjects were dichotomized into whether they had two or 
more of the following conditions at any of the four waves: heart attack, stroke, 
hypertension, diabetes, and hypercholesterolemia, or a coronary artery bypass graft.   
Informant characteristics. Informant characteristics included relation to subject, 
frequency of contact with the subject, age, gender, and how long informants had known 
the subject. Relation was defined as spouse versus non-spouse. Frequency of contact was 
defined as those who lived with the subject versus those who did not live with the 
subject. Age was categorized as less than 65 years old versus 65 years old or older. How 
long the informant had known the subject was defined as less than 55 years old versus 55 
years old or older. To assess whether the informant relationship with the subject and the 
number of years the informant had known the subject were too highly correlated to justify 
examination of each as distinct moderators, I computed Pearson correlations between 
these factors. This analysis, summarized in detail in Appendix B, found these factors to 
be distinct constructs, permitting separate examination of each as a potential moderator of 
associations between depression reports. 
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Data Analysis 
 
Because elapsed time between visits in the CCSMHA multi-stage dementia 
ascertainment protocol varied from 3 to 24 months, analyses conducted for this thesis 
project were restricted to those comparing depression measures within visits. This avoids 
analyses where data source (self, informant, physician) is confounded with elapsed time. 
When comparing depression reports between sources and across time, it would not be 
possible to disentangle extent of disagreement attributable to each of these two factors.  
Additionally, covarying elapsed time would not be sufficient to “correct for” depression 
remission or new-onset depression occurring over the interval. 
 
Research Question 1 
To ascertain the prevalence of major depression as reported by subjects, 
informants, and physicians, I computed the prevalence of major depression on each 
measure, along with the overall prevalence of major depression at each visit, collapsing 
over the multiple depression assessments and counting as depressed if any measure was 
coded as positive for depression.  
To assess basic agreement between these sources, I reported crosstabulations 
within each of the source comparisons examined in this study. Also, I calculated the 
Kappa statistic, a measure of inter-rater agreement of categorical data, which differs from 
traditional inter-rater agreement statistics in that it assesses the proportion of agreement 
beyond agreement which can be attributed to chance. It is computed by dividing the 
number of cases for which raters agree by the total number of cases, subtracting from this 
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the proportion of cases for which agreement between raters could be attributed to chance, 
and then dividing this number by proportion of cases for which agreement cannot be 
attributed to chance. Because raters are more likely to agree that a condition is not present 
if the prevalence of the condition is low, the proportion of cases for which agreement 
between raters could be attributed to chance is computed by taking into account the 
average prevalence of the condition across raters. A Kappa score of 1 indicates perfect 
interrater agreement, a Kappa score of 0 indicates no agreement other than that expected 
by chance, and Kappa scores less than 0 indicate less agreement than that expected by 
chance. To test the statistical significance of Kappa, a null hypothesis of 0 is used, and p 
values are calculated using the normal distribution (Sim & Wright, 2005). Table 3 lists 
the strength of agreement for different ranges of Kappa values as suggested by Landis 
and Koch (1977). 
To further assess the associations between self-report, informant report, and the 
physician report I used Logistic Regression (LR), with the rationale that this approach 
would also facilitate tests of moderation through inclusion of interaction terms, as needed 
 
Table 3 
Strength of Agreement of Values of Kappa 
Kappa statistic Strength of agreement 
<.00 Poor 
0-0.20 Slight 
.21-.40 Fair 
.41-.60 Moderate 
.61-.80 Substantial 
.81-1.00 Almost perfect 
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to address Research Questions 2 and 3 (see below). In models including the MD-Doc, I 
regressed MD-Doc on MD-Informant and MD-Self, since this measure is hypothesized to 
be the “gold standard.”   
In logistic regression models comparing subject and informant reports, I regressed 
subject rating on informant rating in both instances (i.e., MD-Self was regressed on MD-
Informant, and CA-Self was regressed on CA-Informant).  Comparisons between 
informant and subject measures (whether using Kappa or logistic regression) did not 
involve a gold standard, and thus did not ascertain which source is more accurate.  It 
does, however, indicate the extent to which these sources agree.  
Significance in logistic regression models was determined by the Wald and -2 log 
likelihood change (-2LL change) statistics. The -2LL change statistic represents the 
improvement in fit that results from adding a term to the model, which in this case would 
be the depression measure entered as the predictor variable. This statistic is computed by 
subtracting the -2LL statistic from the model with the term in it (in this case, the model 
with the depression variable entered) from the -2LL statistic from the model without the 
term in it (in this case, the intercept only model). Since this statistic is distributed as a 
chi-square statistic, one can determine the significance of this value using a chi-square 
significance table. Typically (though not always) the Wald and -2LL test results are 
consistent, but I took the conservative approach in considering the test of association 
between the two measures to be significant only if both test statistics were significant at 
the p < .05 level.  
In addition, to assess the cut points on the MD-Self and MD-Informant that most 
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closely predict major versus no major depression on the MD-Doc, receiver operating 
characteristic (ROC) analyses were planned but not conducted because of sample size 
issues.  
 
Research Question 2 
To assess whether the associations between self-reports, informant reports, and 
physician’s reports are affected by subject characteristics; original regression models 
were expanded to include subject moderators and their interaction with depression 
measures. A significant interaction term, which was indicated when the Wald statistic and 
the -2LL change statistic (difference between -2LL between model with and model 
without interaction) were significant at the p < .05 level, signified that the association is 
moderated by the subject characteristic tested in the interaction term. Subject moderators 
were tested in all four source comparisons: CA-SELF versus CA-Informant, MD-Self 
versus MD-Informant, MD-Doc versus MD-Self, and MD-Doc versus MD-Informant.  
Each subject characteristic was analyzed separately for potential moderating 
effects. In the MD-Doc versus MD-Self model that tested the dementia moderator, only 
the MCI/OCI and demented categories were used because cognitively normal persons did 
not go to the MD visit. When a subject characteristic had a significant interaction (i.e., 
was found to be a moderator), I then conducted models that included only the source 
comparison, stratified by each level of the subject characteristic. For example, if the 
interaction term that included subject gender was significant, I ran the model that 
included the source comparison among only males, and then the same model among only 
females. These analyses revealed the manner in which the source comparison was 
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affected by the subject characteristic. For instance, the stratified models could reveal that 
the source comparison was significantly associated within only one level of the 
moderator, or they could reveal that the source comparison was more strongly associated 
in one level of the moderator than in another, possibly even in opposite directions.  Each 
of the subject characteristics was tested for potential moderation on the condition that 
adequate sample size conditions were met. Two such conditions had to occur. First, that 
of the 1,481 subjects that participated at the CA visit at either Wave 3 or Wave 4, and of 
the 148 subjects that participated at the MD visit at either Wave 3 or Wave 4, each 
subject moderator had to have no more than 20% missing data. Second, each three-way 
cross-tabulation between the subject moderator and its respective source comparison had 
to contain enough cases in its cells for the model to converge. 
 
Research Question 3 
 For Research Question 3, to assess whether the association between sources was 
affected by informant characteristics, the same approach was used as in Research 
Question 2; original regression models were expanded to include informant variables and 
their interaction with depression measures. Significant interaction terms indicated that the 
association was moderated by the informant characteristic tested in the interaction term, 
and for informant characteristics with significant interactions, I conducted separate 
models stratified by each level of the informant moderator. Informant moderators were 
tested in each of the four source comparisons: CA-SELF versus CA-Informant, MD-Self 
versus MD-Informant, MD-Doc versus MD-Self, and MD-Doc versus MD-Informant. As 
with Research Question 2, each of the informant characteristics was tested on the 
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condition that each informant characteristic had no more than 20% missing data, and that 
each three-way cross-tabulation between the informant characteristic and its respective 
source comparison had enough cases in its cells for the model to converge. 
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CHAPTER IV 
RESULTS 
 
 This chapter reports results of statistical analyses described in the previous 
chapter, to address each of the three research questions in this thesis. Given that there 
were two depression measures collected at the CA and three depression measures 
collected at the MD visit, there are four within-visit comparisons targeted. These include: 
CA-SELF versus CA-Informant, MD-Self versus MD-Informant, MD-Self versus MD-
Doc, and MD-Informant versus MD-Doc, results of which are reported in this chapter, in 
this order, within each research question. Additionally, when reporting results for 
Research Questions 2 and 3, not every subject and informant characteristic was able to be 
examined for moderator effects, due to data limitations. Nevertheless, within each of 
these two sections, I have provided some information—either results of statistical 
analysis or explanation as to data limitation(s) that precluded their examination. This 
information is provided for each of the subject and informant characteristics targeted in 
the prior chapters of this thesis, in the same order, within each research question.   
 
Research Question 1 
 
Research question 1 sought to assess the strength of association between subject 
self-report, informant report, and physician reports of depression. Table 4 reports the 
prevalence of major depression on each measure for each visit, which ranged from 4.4% 
to 23.5%, depending on the measure. This table also indicates that subjects were more 
likely to report major depression than physicians, and that subjects were more likely to  
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Table 4 
Prevalence of Major Depression Per Measure and Per Visit 
CA-Selfa CA-Informantb 
CA visit 
prevalencee  
(n = 1,481) 
MD-
Selfc 
MD-
Informant MD-Docd 
MD visit 
prevalencef 
(n = 148) 
8.4% 4.4% 11.4% 23.5% 13.4% 7.4% 31.8% 
a  PHQ = Patient Health Questionaire-9. 
b  CA/MD-Informant = Neuropsychiatric Inventory from  CA or MD visit. 
c
  MD-Self = Geriatric Depression Scale. 
d
  MD-Doc = Physician’s Clinical Rating. 
e  Proportion of participants who met criteria for major depression on one or more CA depression 
measures. 
f Proportion of participants who met criteria for major depression on one or more MD visit depression 
measures. 
 
report major depression than informants. It also indicates that informants are more likely 
to report major depression than physicians. Generally, prevalence of depression was 
higher at the MD visit than at the CA visit. In addition to reporting the prevalence of 
major depression on the MD-DOC, in Table 5 I also reported the frequency of each 
diagnostic category from that measure. This table indicates that minor depression and 
mood disorder were about as common as major depression, and that bipolar disorder was 
not diagnosed at all. Tables 6 through 9 report crosstabulations within each of the source 
comparisons examined in this study. In general, these tables indicate higher agreement 
between the informant and the physician than between the subject and either the 
informant or the physician. 
Tables 10 and 11 report results from Kappa statistics that tested the agreement 
between source, and from logistic regression models that tested the overall association 
between sources. Agreement between subject and informant reports of depression was 
poor. Although the Wald statistic and the -2LL change are significant in the model  
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Table 5  
 
Number of Persons Diagnosed into Each Category of MD-DOC 
Diagnostic category Frequency % 
No current depression 111 75 
Current major depressive episode 11 7.4 
Current minor depressive episode 11 7.4 
Mood disorder 15 10.1 
Bipolar disorder 0 0 
Total 148  
 
 
Table 6 
 
CA-Self by CA-Informant 
 
CA-Informant 
───────────────────────────   
 
 
no major depression 
──────────── 
major depression 
─────────────  
 
CA-Self n % n % total % 
No major depression 1,197  43  1,240 91.8 
Major depression 100  11  111 8.2 
Total 1,297 96 54 4 1,351 100 
 
 
 
Table 7 
 
MD-Informant by MD-Self 
 
MD-Informant 
───────────────────────────   
 
 
no major depression 
──────────── 
major depression 
─────────────  
 
MD-Self n % n % total % 
No major depression 68  9  77 75.5 
Major depression 20  5  25 24.5 
Total 88 86.3 14 13.7 102 100 
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Table 8 
 
MD-Doc by MD-Self 
 
MD-Doc 
───────────────────────────   
 
 
no major depression 
──────────── 
major depression 
─────────────  
 
MD-Self n % n % total % 
No major depression 99  5  104 76.5 
Major depression 28  4  32 23.5 
Total 127 93.4 9 6.6 136 100 
 
 
Table 9 
 
MD-Doc by MD-Informant 
 
MD-Doc 
───────────────────────────   
 
 
no major depression 
──────────── 
major depression 
─────────────  
 
MD-Informant n % n % total % 
No major depression 89  4  93 86.1 
Major depression 10  5  15 13.9 
Total 99 91.7 9 8.3 108 100 
 
 
Table 10 
 
Kappa for Source Comparisons 
Source comparison Kappa 
MD-Doca / MD-Selfb  0.1 
MD-Doc / MD-Informantc  0.35*** 
CA-Selfd/ CA-Informant 0.08*** 
MD-Informant / MD-Self 0.01* 
a MD-Doc =Physician’s Clinical Rating. 
b MD-Self = Geriatric Depression Scale. 
c CA/MD-Informant=Neuropsychiatric Inventory. 
d PHQ-=Patient Health Questionaire-9. 
*p < .05 
*** p < .001 
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Table 11 
 
Regression Models for Overall Source Comparisons 
Source n size OR 95% CI of OR Wald -2LL change 
CA-Self d / CA-Informant e  1,351 3.1 1.5 6.1 10.1** 8.2** 
MD-Informant / MD-Self f  102 1.9 0.6 6.3 1.1 1 
MD-Doc a / MD-Self b g  136 2.8 0.7 11.2 2.2 2.1 
MD-Doc a / MD-Informant c h  108 11.1 2.6 48.3 10.3** 9.9** 
 
a MD-Doc =Physician’s Clinical Rating. 
b MD-Self = Geriatric Depression Scale. 
c CA/MD-Informant = Neuropsychiatric Inventory. 
d PHQ = Patient Health Questionaire-9. 
e CA-SELF regressed on CA-Informant. 
f MD-Informant regressed on MD-Self. 
g MD-Doc regressed on MD-Self. 
h MD-Doc regressed on MD-Informant. 
*p < .05. 
** p <.01. 
  
assessing the association between the CA-Self and the CA-Informant (p < .01), the Kappa 
statistic was only .08 (p = .001), indicating poor agreement. Table 11 also contains results 
from the model comparing the MD-Informant and the MD-Self. For this model, the Wald 
statistic, the -2LL change, and the Kappa statistic (κ =.1, p = .30) were not significant.  
Subject reports and physician reports of depression were found to be virtually 
unrelated. In the model comparing the (MD-Doc) and the MD-Self, neither the Wald 
statistic nor the -2LL change are significant, indicating that the MD-Self cannot predict 
outcomes on the MD-Doc. The Kappa statistic for these measures (κ =.1, p = .13) was 
also not significant.  
 In contrast, informant reports and physician reports were related, and the 
association between these sources was moderate. In the model comparing the MD-Doc 
and NPI informant reports from the MD visit, both Wald statistic and -2LL change are 
60 
 
  
significant at the p < .01 level, and Kappa indicates fair agreement (κ = .35, p < .001). 
Because only nine persons were diagnosed with major depression on the MD-Doc, I was 
unable to conduct ROC analyses, which were designed to find the optimal cutoffs on the 
MD-Self and MD-Informant for predicting cases and noncases on the MD-Doc.  
 
Research Question 2 
 
 Research question 2 seeks to ascertain whether the association between subject 
self-report and physician report of major depression, and the association between subject 
self-report and informant report of major depression, are moderated by subject 
characteristics. Table 12 summarizes demographic characteristics of subjects. This table 
indicates that on none of these characteristics are subjects missing more than 20% of the 
data. However, in the MD-Doc by MD-Self model that included the subject age 
moderator, and in the MD-Doc by MD-Informant models that included the subject age 
and prior depression history moderators, crosstabulations indicated sparse data in some 
cells that precluded testing this moderator (see Tables B17, B23, and B25, respectively, 
in Appendix B). 
 
CA-Self Versus CA-Informant 
Table 13 reports interactions from the CA-Self by CA-Informant source 
comparison. Nearly all of the Wald and -2LL statistics testing for significant moderation 
by subject characteristics were not significant, indicating no moderating effects of the 
examined variables.  The exception was the cognitive status moderator. The Wald and 
-2LL change statistics for the interaction are not significant. However, the Wald statistic 
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Table 12 
 
Demographic Summary of Subjects 
 
CA visit 
─────────── 
MD visita 
─────────── 
Variable n % n % 
Subject gender     
 Males 636 42.9 61 41.2 
 Females 844 57 87 58.8 
 Missing 1 0.1 0 0 
Subject age     
 < 85 years old 961 64.9 85 57.4 
 85+ years old 517 34.9 63 42.6 
 Missing 3 0.2 0 0 
Cognitive impairment     
 Normal 624 42.1 10 6.8 
 MCI/OCI 628 42.4 95 64.6 
 Dementia 228 15.4 1 .7 
 Missing 1 .1   
Prior depression history     
 No prior depression 1,198 80.9 117 79.1 
 Prior depression 226 15.3 26 17.6 
 Missing 57 3.8 5 3.4 
Medical conditions     
 Had < 2 medical conditions 569 38.4 52 35.1 
 Had 2+ medical conditions 912 61.6 96 64.9 
 Missing 0 0 0 0 
Medication use     
 Not taken meds 1,134 76.6 113 76.4 
 Taken meds 346 23.4 34 23 
 Missing 1 0.1  1  .7 
a  Based on the total number of persons that took either the MD-Doc or MD-Self at 
the MD visit. 
 
for the normal versus MCI/OCI comparison is significant at the p < .05 level. To further 
study this interaction, I stratified the CA-Self versus CA-Informant source comparison by 
cognitive status. Table 14 reports results for these models. As can be seen, the Wald 
statistic and -2LL are significant for only cognitively normal subjects, that is, only the 
cognitively normal subjects had significant association between these two measures. In 
addition, in Table 15 I report Kappa statistics for the CA-Self by CA-Informant source
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Table 14 
 
CA-Self Regressed on CA-Informant for Each Level of Cognitive Impairment 
Cognitive impairment  n size OR 95% CI of OR Wald -2LL change 
Normal 592 10.1 1.9 52.6 7.6** 5.1* 
MCI/OCIa 580 1.2 0.4 4.3 0.1 0.1 
Dementia 179 2.7 0.9 7.8 3.4 3.1 
 
a MCI/OCI = mild cognitive impairment/other cognitive impairment. 
* p < .05. 
** p < .01. 
 
 
Table 15 
 
Kappas for CA-Informant by CA-Self for 
Each Level of Cognitive Status 
 
Cognitive status Kappa p value 
Cognitively normal 0.13 0.001 
MCI/OCIa 0.01 0.75 
Demented 0.14 0.06 
a MCI/OCI = mild cognitive impairment/other 
cognitive impairment. 
 
comparison for each level of cognitive status. This table indicates, that although 
agreement between the CA-Self and CA-Informant was highest among demented persons 
(κ = 0.14), only agreement on these measures among cognitively normal persons (κ = 
0.13) was significant.   
 
MD-Self Versus MD-Informant, MD-Doc  
Versus MD-Self, MD-Doc Versus  
MD-Informant 
Tables 16-18 report interactions used in the models testing the associations 
between the MD-Self and the MD-Informant, the MD-Doc and the MD-Self, and the 
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MD-Doc and the MD-Informant. The Wald statistics and -2LL changes for these 
interactions are not significant, indicating no moderating effects of examined variables.  
 
Research Question 3 
 
 
Research question 3 seeks to ascertain whether the association between informant 
reports and physician reports of major depression, and the association between informant 
reports and subject self-reports of major depression, are moderated by informant 
characteristics. Table 19 summarizes demographic characteristics of subjects. This table 
indicates that all informant characteristics at the MD visit were missing on more than 
20% of the sample (most were missing on more than 75%), thus precluding any tests for 
moderation by informant characteristics on any of the three MD visit comparisons. At the 
CA visit, informant characteristics were likewise missing on more than 20% of the 
sample for all but the following: informant gender, informant relationship and informant 
frequency of contact.  However, as regards the “sparse cell” problem, the test for 
moderating effect of informant gender was not possible due to sparse cells in the 3-way 
table (see Table B31 in Appendix B), thus limiting tests for moderation by informant 
characteristics to only informant relationship and informant frequency of contact for the 
one comparison at the CA visit. Thus, the only informant characteristics that could be 
examined were informant relationship and informant frequency of contact at the CA visit. 
 
CA-Self Versus CA-Informant 
Table 20 reports results from informant moderators tested in the CA-SELF versus 
CA-Informant source comparison. The Wald and -2LL change statistics are not  
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Table 19 
 
Demographic Summary of Informants 
 
 
CA visit 
────────── 
MD visita 
─────────── 
Informant variables n % n % 
Informant relationship     
 Spouse 653 44.1 18 12.2 
 Non-spouse 681 46 16 10.8 
 Missing 147 9.9 114 77 
Informant frequency of contact     
 Lives w/ subject 717 48.4 9 6.1 
 Not lives w/ subject 537 36.3 3 2 
 Missing 227 15.3 136 91.9 
Informant age     
 Less than 65 years old 253 17.1 11 7.4 
 65+ years old 743 50.2 20 13.5 
 Missing 485 32.7 117 79.1 
Informant gender     
 Males 400 27 3 2 
 Females 937 63.3 11 7.4 
 Missing 144 9.7 134 90.5 
Years Informant known subject     
 Less than 55 years  541 36.5 9 6.1 
 55+ years  550 37.1 14 9.5 
 Missing 390 26.3 125 84.5 
a Based on the total number of persons that took either the PCR or GDS at the MD visit 
 
Table 20  
 
CA-Self Regressed on CA-Informant: Informant Moderators 
Variable  n size OR 95% CI of OR Wald -2LL change 
CA-Informantb  x CA visit informant 
relationship (spousea versus non-spouse)  1,222 1.0 0.2 4.4 0.0 0.0 
CA-Informant x CA visit inf. freq. of contact 
(lives w/ subjecta versus not lives w/) 1,151 1.2 0.3 5.2 0.1 0.1 
a Reference category 
b NPI= Neuropsychiatric Inventory 
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significant for any of the moderators. These results indicate that agreement between the 
informant and other sources is moderated by none of the informant characteristics tested. 
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CHAPTER V 
DISCUSSION 
 
This study estimated the extent to which information from physicians’ 
assessments of geriatric depression could be predicted by subjects’ assessments and 
informants’ assessments of geriatric depression, and the extent to which informants’ 
assessments and subjects’ assessments of geriatric depression could predict each other. 
Results indicated that, overall, CCMS agreement was best between informants and 
physicians. These sources agreed fairly well, with informants being slightly more likely 
to report depression than physicians. Agreement between subjects and both informants 
and physicians was poor, with subjects being more likely to report depression than the 
other sources. 
Poor agreement on some comparisons may have occurred because different 
measures were used for different sources. Previous studies provide mixed support for 
this. For instance, one previous study (McAvay et al., 2005) that used the same 
measure—The Structured Clinical Interview for Axis I DSM-IV Disorders—with 
subjects and informants found fair to moderate agreement between subjects and 
informants on psychological symptoms of depression (diminished interest or pleasure, 
depressed mood, worthlessness, inappropriate guilt), suicidal symptoms of depression 
(thoughts of death, suicidal ideation), and somatic symptoms of depression (decreased 
appetite or weight loss, increased appetite or weight gain, psychomotor agitation or 
psychomotor retardation, insomnia or hypersomnia, fatigue or loss of energy) 
(psychological: κ =.41, suicidal: κ =.41, somatic: κ =.31). However, this study also found 
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poor agreement on cognitive symptoms (indecisiveness or diminished ability to 
concentrate or think; κ =.09). In addition, Ott and Fogel (1992) found that agreement 
between sources to be high despite the fact that they used different measures. In this 
study, caregivers and clinicians agreed quite well (r = 0.92), and subjects and clinicians 
agreed moderately well (r = 0.40), despite the fact that subjects, caregivers, and clinicians 
used different measures (the GDS, the HAM-D), and the Cornell Depression Scale for 
Depression in Dementia, respectively). However, the latter two of these three measures 
are different measures than those used in the present study.  
 Differences between this and previous studies may also have occurred because 
subjects in the Cache County Study on Memory and Health in Aging are different in 
some regards than participants in previous studies. For instance, subjects in the CA and 
MD samples had a mean age of 83.0 years (SD = 5.3) and 85.1 years (SD = 5.8), while 
participants in previous studies had mean ages that ranged from 74 to 78. This could 
account for lower agreement found in this study, since younger subjects tend to be less 
concerned about stigma related to reporting depression, thus increasing the likelihood that 
they will report symptoms. In general, prevalence of depression was higher in this study 
than in previous studies that assessed prevalence of depression among the elderly. In this 
study, the percentage of persons having major depression ranged from 4.4% on the CA-
Informant to 23.% on the MD-Self, whereas in previous studies the percentage of persons 
having major depression ranged from 0.86% to 9.4% (Beekman et al., 1995; Djernes, 
2006; Eaton et al., 2007; Steffens et al., 2000). This higher prevalence may have occurred 
because subjects in this study were older than subjects in previous studies. Ethnic 
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composition was also different in this study; 99.1% of participants in the CA sample were 
White, whereas 83.9% and 88% of participants in McAvay and colleagues’ (2005) study 
and Snow and colleagues’ study (2005), respectively, were White. It is unclear what 
difference this could have made in agreement. In addition, the religious composition at 
the CA sample consisted mostly of LDS persons (91.6%), which may have affected 
agreement. Participants in the CA sample were similar to participants in previous studies 
in terms of gender composition and education.  
This study and previous studies may also have differed because of differences in 
samples used. Whereas previous studies used participants from clinical samples or 
participants receiving medical home care services, the present study used a population. 
This makes participants in the Cache County Study more representative of persons in the 
U.S. population in general. Subjects and informants that acquire services from clinics 
tend to be different from those in the general population. For instance, Kokmen, 
Özsarfati, Beard, O’Brien, and Rocca (1996) found that persons in a clinic-based sample 
of elderly persons were more likely to be married, to be white collar workers, and to be 
highly educated than persons in a population-based sample of elderly persons. Those with 
higher education and occupational status are more likely to have educated beliefs about 
mental illness, which makes them more likely to report symptoms of depression.  Thus, 
the population-based sample of participants in the Cache County Study is generally more 
representative of persons in the U.S. population in general, at least insofar as bias due to 
self-selection to use medical services is concerned.  Agreement on depression assessment 
may be higher among individuals in the subpopulation who seek medical attention. This 
72 
 
  
may be particularly true when seeking medical care for depressive symptoms, as this 
behavior likely stems from higher levels of awareness on the part of subject and 
informant regarding depressive symptoms, perhaps also enhanced by discussion between 
subject and family members concerning subject’s depression, when seeking medical care. 
Another key factor that may play a role in this study having relatively poor 
agreement between subjects and informant ratings is that different measures were used 
with subjects and informants to assess depression. One way in which depression 
measures differed is in the length of time over which symptoms were inquired. For 
instance, the CA-Informant inquires about symptoms in the previous month, while the 
CA-Self inquires about symptoms over the previous 2 weeks. This may have caused 
informants to be more likely to report symptoms than the subject. However, in this study 
subjects reported depression on the CA-Self more often than on the CA-Informant, 
indicating that subjects reported more depression net of these differences. This suggests 
that differences between the CA-Self and CA-Informant are due not only to differences in 
the length of time over which symptoms were inquired, but also to differences between 
sources. 
These measures also differed in that informants are given all of the items on the 
CA-Informant only if they respond affirmatively on the gateway question, “In the last 
month, did (NAME) seem sad or depressed?  Does (NAME) say that (HE/SHE) feels sad 
or depressed?” Some older adults manifest depression but without the hallmark symptom 
of sadness (Gallo & Rabins, 1999). In such cases, informants may still have endorsed 
enough of the individual items to constitute a diagnosis of major depression disorder.  
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Thus, it is possible that on this measure depression is less likely to be endorsed than on 
other measures, such as the CA-SELF. However, if differences between subject reports of 
depression (as measured by the MD-Self and CA-SELF) and CA-Informant or MD-
Informant informant reports of depression were due primarily to the decreased likelihood 
of depression endorsement on the CA-Informant or MD-Informant due to the gateway 
question, one would still expect that subjects that were rated as depressed on the CA-
Informant or MD-Informant would be also rated as depressed on the MD-Self or CA-
Self. Tables 5 and 6 suggest otherwise. Table 5 indicates that only 11 out of the 54 
persons diagnosed as depressed on the CA-Informant were diagnosed as depressed on the 
CA-Self, and Table 6 indicates that only 5 out of 14 persons diagnosed as depressed on 
the MD-Informant were diagnosed as depressed on the MD-Self, which indicates that 
disagreement between subjects and informants is not due exclusively to the decreased 
likelihood of depression endorsement on the CA-Informant or MD-Informant due to the 
gateway question, but also to differences between sources.  
Disagreement between sources may also be due to differences between items on 
the depression measures. Table 21 explores this possibility. This table compares 
symptoms queried in the MD-Self, CA-Self, and NPI and compares these measures to 
DSM-IV criteria for major depression. This table indicates that the MD-Self has more 
items on depressed mood than the CA-Informant. However, because the MD-Self as a 
whole has twice as many items as the NPI (assuming that participants answer all items), 
the number of items addressing depressed mood on the MD-Self is not proportionately 
larger than number of items on the NPI. Table 21 also indicates that the MD-Self has  
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Table 21 
 
Comparison of Depression Items 
DSM-IV criteria for major 
depression MD-Self NPI CA-Self 
Depressed mood 7.  Are you in good spirits most of 
the time? 
3.  Sad or in low spirits  
 25.  Do you frequently feel like 
crying? 
2.  Tearfulness or sobbing  
 16.  Do you often feel downhearted 
and blue? 
 Seemed sad or depressed 
(gateway question) 
2.  Feeling down, 
depressed, or 
hopeless 
 9.  Do you feel happy most of the 
time? 
  
 15.  Do you think it is wonderful to 
be alive now? 
  
 1.  Are you basically satisfied with 
your life? 
  
Diminished interest or 
pleasure 
2.  Have you dropped many of your 
activities and interests? 
 1. Little interest or 
pleasure in doing 
things 
 12.  Do you prefer to stay at home, 
rather than going out and doing 
new things? 
  
 19.  Do you find life very exciting?   
Weight loss or weight gain   6 & 7. Poor appetite/ 
overeating 
Insomnia or hypersomnia 27.  Do you enjoy getting up in the 
morning? 
 3 & 4. Trouble falling 
asleep or staying 
asleep/sleeping too 
much 
Psychomotor agitation or 
retardation 
11.  Do you often get restless and 
fidgety? 
5. Irritable 10 & 11. Moving or 
speaking slowly/ 
fidgety and restless 
Fatigue or loss of energy 21.  Do you feel full of energy?   
Feelings of worthlessness 
or excessive or 
inappropriate guilt 
3.  Do you feel that your life is 
empty? 
11. Says life is not 
worthwhile 
 
 17.  Do you feel pretty worthless the 
way you are now? 
13.  Feels worthless  
  8.  Puts self down, feels like 
a failure 
8.  Feeling bad about 
self/that they are a 
failure/let family 
down 
  9.  Says they’re a bad 
person, deserves to be 
punished 
 
  12.  Says family would be 
better off without 
him/her 
 
(table continues)
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DSM-IV criteria for major 
depression MD-Self NPI CA-Self 
Diminished ability to think 
or concentrate, or 
indecisiveness 
26.  Do you have trouble 
concentrating? 
 9. Trouble 
concentrating 
 14.  Do you feel you have more 
problems with memory than 
most? 
  
 6.  Are you bothered by thoughts 
you can’t get out of your head? 
  
 29.  Is it easy for you to make 
decisions? 
  
 30.  Is your mind as clear as it used 
to be? 
  
Recurrent thoughts of 
death, suicidal ideation, 
suicide attempt/plan 
 14. Wishes for death, talks 
about killing self 
12.  Thinks they are 
better off 
dead/thoughts about 
hurting self 
  15.  Tried to commit suicide  
Distress, problems in 
social/ occupational 
functioning 
20.  Is it hard for you to get started 
on new projects? 
 
 
 28.  Do you prefer to avoid social gatherings? 
  
Other symptoms    
 Helplessness/ 
hopelessness 
5.  Are you hopeful about the 
future? 
10.  Discouraged, says they 
have no future  
 10.  Do you often feel helpless?   
 22.  Do you feel that your situation is hopeless? 
  
 Worry 8.  Are you afraid that something bad is going to happen to you? 
  
 13.  Do you frequently worry about the future? 
  
 18.  Do you worry a lot about the past? 
  
 Other 4.  Do you often get bored?   
 23.  Do you think that most people are better off than you are? 
  
 24.  Do you frequently get upset over little things? 
  
  1.  Currently being treated for depression  
  7.  Mood changes a lot  
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items that address criteria that the NPI does not address, such as insomnia or 
hypersomnia, fatigue or loss of energy, lack of concentration or indecisiveness, and 
distress or problems in social or occupational functioning, indicating that the MD-Self 
addresses a broader range of criteria than the NPI does. This gave subjects a broader 
range of symptoms to endorse, which may have increased the likelihood that subjects 
endorsed enough symptoms to render a diagnosis of depression. The MD-Self also 
contains items that, if not endorsed, indicate depression. For instance, one of the items 
states, “Do you feel happy most of the time?” and another states, “Do you enjoy getting 
up in the morning?” If subjects do not endorse items such as these, one point is added to 
their score. Because these items are not as directly related to depression, subjects that do 
not have depression may be more likely to not endorse them, which would increase their 
total score, making it more likely that their total scores exceeds the threshold for major 
depression. In addition, the MD-Self contains items that elderly persons would endorse 
even if they weren’t depressed, such as “Have you dropped many of your activities and 
interests?,” “Do you prefer to stay at home, rather than going out and doing new things?,” 
“Do you find live very exciting?,” and “Do you feel full of energy?.” Items such as these 
make it more likely that elderly persons who are not depressed exceed the threshold for 
major depression. 
 The effect of differences between the CA-Self and CA-Informant on agreement 
between sources is equivocal. Although the CA-Self addresses criteria that the CA-
Informant does not (diminished interest or pleasure, and insomnia or hypersomia) and 
thus addresses a broader array of symptoms, the CA-Informant has proportionately more 
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items addressing feelings of worthlessness or excessive or inappropriate guilt, and thus 
addresses this criterion in more depth. It is unclear how these differences would cause 
disagreement between these sources.  
 Poor association between depression reports may also have been due to various 
statistical issues. For instance, poor association between subject reports of depression and 
physician and informant reports of depression, relative to the higher association between 
informants and physicians, may have occurred because only eleven subjects were 
diagnosed as depressed on the MD-Doc, and of these, only nine were used in analyses. 
This reduces statistical power to detect associations. However, informants and physicians 
agreed moderately well despite the low number of persons diagnosed as depressed on the 
MD-Doc, and subjects and informants on the CA-Self and CA-Informant, respectively, 
agreed poorly, despite the large number of persons diagnosed as depressed on these 
measures (115 and 63), indicating that the relatively lower association between subject 
reports and physician and informant reports of depression, relative to the higher 
association between informant reports and physician reports, was only partly due to this 
sample size issue. Also, poor association between depression reports may have occurred 
because I dichotomized depression reports into major depression versus not major 
depression. This decreases power to detect associations because it ignores information 
about differences between persons in the same group (MacCallum, Zhang, Preacher, & 
Rucker, 2002).   For example, an alternative coding of “any depression” versus “no 
depression” would have resulted in the former group having higher frequency (and 
therefore higher power). 
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Similar to this study, previous studies found agreement between sources to be 
unaffected by most subject and informant characteristics. For instance, McAvay and 
colleagues (2005) found agreement between sources to be unaffected by subject gender, 
informant gender, and informant frequency of contact, although they also found that 
younger informants reported more psychological and cognitive symptoms than older 
informants. Snow and colleagues (2005) found that physical illness, functional status and 
caregiver burden did not predict discrepancies between subject and informant reports of 
depression, and between subject and clinician reports of depression. Similarly, Ott and 
Fogel (1992) found that history of depression, age, sex, and education could not predict 
discrepancies between self-reports and clinician reports.  
However, also similar to the present study, previous studies found that cognitive 
impairment is associated with lower agreement between sources. For instance, McAvay 
and colleagues (2005) found that agreement between cognitively impaired subjects and 
their informants on the cognitive symptoms of depression (indecisiveness or diminished 
ability to concentrate or think) was lower than agreement on these symptoms among 
cognitively normal persons and their informants. Snow and colleagues (2005) found that 
among persons with a previous diagnosis of dementia, awareness of dementia predicted 
discrepancies between subject and informant reports of depression, and between subject 
and clinician reports of depression. Ott and Fogel (1992) found that the correlation 
between subject and clinician reports of depression was lower among subjects with 
cognitive impairment. Teri and Wagner (1991) found that dementia severity did not 
affect agreement. However, this may have occurred because all of the persons in their 
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sample had AD; although dementia severity can vary among persons with AD, range of 
dementia severity varies less widely among these persons than among the entire range of 
not demented versus demented persons. Having only persons with AD would restrict 
range thereby limiting power to observe effects of dementia severity.   
This study has found that other informant and subject characteristics did not affect 
agreement between sources. This is surprising given previous findings (summarized in 
Chapter II) regarding these characteristics; that older persons are more likely to associate 
stigma with depression (Roeloffs et al., 2003), that older males with major depression are 
less likely to seek treatment (antidepressants and psychotherapy) than older females with 
major depression (Hinton et al., 2006), and so forth. These findings may have differed 
from this study because subjects were younger in previous studies. However, some 
studies were missing specific age information. For instance, Roeloffs and colleagues 
reported only that the age of participants in their sample ranged from 18 to 90 years and 
that 55.7% of their sample was older than 41 years old. Hinton and colleagues, who did 
report specific age information, subject age was comparable to this study; 41.7% of 
participants in Hinton and colleagues’ study were 65-74 years old, and 35.21% of 
participants study were 75 and older.  
 
Limitations 
 
Some limitations to the present study can be noted. This study analyzed 
agreement between sources using different measures for each source. This to some extent 
confounds conclusions regarding the strength of agreement between sources. 
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Unfortunately, some analyses in this study were precluded by scarce data on informant 
characteristics. Also, because the main focus of the MD visit was to diagnose dementia, 
physicians may not have dedicated as much time to diagnosing depression as they would 
have if their main focus had been diagnosing depression.  Further, this study’s physician 
visit comparisons were limited because no cognitively normal subjects were included and 
the MD visit.  Thus, because study physicians understood that the study protocol only 
selected subjects for this visit who were initially diagnosed with dementia or 
subsyndromal AD, they may have tended to discount subject’s self-report, placing more 
emphasis on informant report than on the cognitively impaired subject’s report. 
 
Strengths 
 
This study had the advantage of utilizing population-level data, which increases 
representativeness. Also, this study is unique in that it included a higher proportion of 
individuals in the oldest-old group (aged 85 and older), providing insights into depression 
assessment in this group not included in many studies. In addition, this study utilized a 
cognitive status moderator that consisted of an in-depth dementia ascertainment protocol, 
instead of a simple cognitive screening test used in some studies.  
 
Clinical and Scientific Relevance 
 
Findings from this study help clarify uncertainties regarding the diagnosis of 
depression in late-life. This information can be valuable to clinicians in their work with 
elderly persons, in that it could help them identify conditions under which subjects differ 
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the most from informants and physicians (i.e., subjects differ the most when they have 
mild cognitive impairment and when they are demented). In addition, this information is 
invaluable to epidemiologic researchers who study dementia and depression. Finding 
presented in this study elucidate the strengths and shortcoming of various rating sources 
of depression, and underscores the importance of carefully selecting depression measures 
when diagnosing depression among the elderly.  Findings from this study also underscore 
the importance of triangulation in assessing depression among this population, 
particularly when the subject has notable cognitive impairment. 
 
Future Directions 
 
Because this and previous research indicates that agreement is higher between the 
informant and physician, future research should further explore informant moderators 
associated with higher agreement with the physician, with the goal of finding strata of 
informant characteristics most highly associated with agreement with the physician, to 
profile “the ideal informant.”  In addition, future research should be focused on becoming 
more aware of differences between studies using clinic-based data and those using 
population-based data in findings regarding rating sources of late-life depression. Finally, 
qualitative studies may be an important way to understand the phenomenology of 
depression in late life and what factors influence informants and older adults to feel 
comfortable disclosing (and even to be aware of) depression. 
 
  
82 
 
  
Summary 
 
This study found agreement in late-life depression to be highest among 
informants and physicians. Agreement in late-life depression among subjects and both 
informants and physicians was found to be poor. This agreement was worse than that 
found in previous studies. However, because this study examined age groups older than 
those used in previous studies, differences in findings in this study likely reflect unique 
phenomena among the oldest old. In addition, because this study utilized population-
based data while previous studies used clinical-based data, differences in this study may 
also reflect a more representative view of the U.S. population. Poor agreement on some 
comparisons occurred in part because different measures were used for different sources. 
However, this study elucidates differences between these measures that may account for 
differences in agreement. 
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Physician’s Clinical Evaluation of Depression
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Cache County Study on Memory Health and Aging 
Physician’s Clinical Impression of Depressive Disorder 
 
 
Subject ID#:  ______________  Date of visit:  _______________________ 
 
Physician ID#:  ____________ 
 
Physician is to select one of the following codes that most closely corresponds to his/her 
clinical impression of the presence of depressive disorder in the participant at the time of 
the MD visit.  This impression is not intended to be a clinical diagnosis or an assessment 
of whether or not the participant meets explicit DSM algorithmic criteria, and does not 
assume a complete psychiatric evaluation has been conducted.  Rather, it is the 
physician’s overall clinical impression for the purposes of assigning a “working research 
diagnosis.”  This diagnosis is determined through information gathered from the subject 
directly and the collateral informant, including the Geriatric Depression Scale which is 
self-administered by the subject (Criteria are listed below only as a guide.) 
 
____ (100)  no current depression   ____ (400) mood disorder NOS 
 
____ (200)  current major depressive episode ____ (500) bipolar disorder 
 
____ (300)  current minor depressive episode 
 
 
Major Depressive Episode 
In the same 2 weeks, the patient has had 5 or more of the following symptoms, which are 
a definite change from usual functioning. Either depressed mood or decreased interest or 
pleasure must be one of the five. 
1. Mood. For most of nearly every day, the patient reports depressed mood or 
appears depressed to others. 
2. Interests. For most of nearly every day, interest or pleasure is markedly 
decreased in nearly all activities (noted by the patient or by others). 
3. Eating and weight. Although not dieting, there is a marked loss or gain of 
weight (such as five percent in one month) or appetite is markedly 
decreased or increased nearly every day. 
4. Sleep. Nearly every day the patient sleeps excessively or not enough. 
5. Motor activity. Nearly every day others can see that the patient’s activity 
is agitated or retarded. 
6. Fatigue. Nearly every day there is fatigue or loss of energy. 
7. Self-worth. Nearly every day the patient feels worthless or inappropriately 
guilty. These feelings are not just about being sick; they may be 
delusional. 
8. Concentration. Noted by the patient or by others, nearly every day the 
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patient is indecisive or has trouble thinking or concentrating. 
9. Death. The patient has had repeated thoughts about death (other than the 
fear of dying), suicide (with or without a plan) or has made a suicide 
attempt. 
 
Additional criteria: 
 These symptoms cause clinically important distress or impair work, social or 
personal functioning. 
 They don’t fulfill criteria for Mixed Episode.  
 This disorder is not directly caused by a general medical condition or the use of 
substances, including prescription medications.  
 Unless the symptoms are severe (defined as severely impaired functioning, severe 
preoccupation with worthlessness, ideas of suicide, delusions or hallucinations or 
psychomotor retardation), the episode has not begun within two months of the 
loss of a loved one.  
 
Minor Depressive Episode 
The symptom features and duration are identical to that of major depressive episode with 
the exception that fewer symptoms are needed to meet diagnostic criteria (2 out of 9 with 
1 of the 2 being depressed mood or loss of interest or pleasure). Exclusionary criteria 
include a past episode of major depression or dysthymia.  In addition, the significant 
distress or impairment criterion found in major depression has been omitted. 
 
Bipolar Disorder 
Bipolar disorder has a clinical course that is characterized by the occurrence of one or 
more Manic episodes or Mixed episodes.  Often individuals have also had one or more 
Major Depressive episodes.  Episodes of Substance-induced Mood Disorder or of Mood 
Disorder Due to a General Medical Condition do not count toward a diagnosis of Bipolar 
I Disorder.  
 
Mood Disorder NOS 
This category includes disorders with mood symptoms that do not meet the criteria for 
any specific mood disorder and in which it is difficult to choose between Depressive 
Disorder NOS and Bipolar Disorder NOS. 
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Supplementary Investigations
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SUPPLEMENTARY INVESTIGATIONS 
 
 
 This section describes supplementary descriptive statistics and analyses. These 
descriptions proceed in the order in which they were originally mentioned in this study. 
First, I describe the process by which I selected cases from Waves 3 and 4, and then 
report analyses assessing the equivalence on a number of demographic factors of 
participants taken from these time points. I then describe the mean imputation procedure I 
used for the CA-Self.  Next, I describe the process by which I determined 
multicollinearity between informant relationship and number of years the informant had 
known the subject. Finally, I include tables reporting cell size for models that included 
moderator variables.   
 
Selecting Between Waves 3 and Wave 4 
 
To ensure independence of observations, I used subjects’ data from only one 
wave. I used Wave 3 data if the subject completed Wave 3. Otherwise, I used Wave 4 
data.  This protocol was followed separately for CA and MD visit, such that if a subject 
had CA in both Waves 3 and 4, but MD visit only in Wave 4, then Wave 3 CA data and 
Wave 4 MD visit data were used for that subject.  The total number of participants used 
for each measure overall and within each wave, are listed in Table B1. The MD-Doc and 
MD-Self were added mid-way through Wave 3 fieldwork. Because of this, only 127 of 
the 357 persons that participated in Wave 3 were given these measures, and of these, 124 
completed the MD-Doc and 112 completed the MD-Self.  
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Table B1 
 
Number of Persons from Each Wave 
Participant Wave 3 used Wave 4 used Total 
CA-Informant 1,203 243 1,446 
PHQ_9 1,135 238 1,373 
MD-Informant 279 20 299 
MD-Self 112 24 136 
MD-Doc 124 24 148 
subject dementia status 1,228 252 1,480 
CA visit subject age 1,226 252 1,478 
MD visit subject age 357 25 382 
medications 1,228 252 1,480 
CA visit informant rel. to subject 1,087 247 1,334 
CA visit informant freq. of contact 1,039 215 1,254 
CA visit informant age 756 240 996 
CA visit informant gender 1,090 247 1,337 
CA visit years informant known subject 861 230 1,091 
MD visit informant rel. to subject 45 19 64 
MD visit informant frequency of contact 41 0 41 
MD visit informant age 39 19 58 
MD visit informant gender 44 0 44 
MD visit years informant known subj. 35 12 47 
 
 
Equivalence of Waves 3 and 4 on Demographic Factors 
 
To determine equivalence across a range of demographic variables between 
subjects whose data were from Wave 3 versus from Wave 4, chi-square tests of 
independence were conducted (see Table B2). As can be seen, the CA and MD-
Informant, MD-Self, MD-Doc, MD visit subject age, CA visit informant relationship to 
subject, CA visit informant frequency of contact, CA visit informant gender, CA visit 
years the informant had known subject, MD visit informant relationship to subject, MD 
visit informant frequency of contact, MD visit informant age, and MD visit years the 
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Table B2 
 
Wave 3 and Wave 4 Differences 
 
Category Chi square p value 
CA-Informant (major dep vs no major dep) 0.2 0.63 
PHQ 9-CA (major dep vs no major dep) 5.4 0.02 
MD-Informant (major dep vs no major dep) 2.5 0.11 
MD-Self (major dep vs no major dep) 0.5 0.47 
MD-Doc (major dep vs no major dep) 0.0 0.85 
subject dementia (normal, MCI/OCI, dementia) 7.9 0.02 
CA visit subject age (<85 versus 85+ yrs. old) 11.3 0.00 
MD visit subject age (<85 versus 85+ yrs. old) 0.4 0.54 
medications (meds taken versus not taken) 7.8 0.01 
CA visit informant rel. to subject (spouse versus non-spouse) 3.3 0.07 
CA visit informant freq. Of contact (lives with subj vs not lives with) 0.0 0.89 
CA visit informant age (<65 versus 65+ yrs. old) 35.6 <.001 
CA visit informant gender 1.6 0.21 
CA visit years informant known subj. (<55 versus 55+ yrs.) 5.0 0.03 
MD visit informant rel. to subject (spouse versus non-spouse) 0.4 0.51 
MD visit informant freq. Of contact (lives with subj vs not lives with) * * 
MD visit informant age (<65 versus 65+ yrs. old) 0.0 0.94 
MD visit informant gender * * 
MD visit years informant known subj. (<55 versus 55+ yrs.) 0.1 0.78 
 
 
informant had known subject were nonsignificant, indicating that Wave 3 participants 
were the same as Wave 4 participants on these factors. 
Conversely, Wave 3 and Wave 4 subjects were found to differ on cognitive status- 
Wave 4 subjects were less likely to be MCI/OCI or demented than Wave 3 subjects. The 
may be due to the method by which I decided which wave to use for each subject, 
described previously. Subjects for whom I used Wave 4 data were subjects who did not 
pass the cognitive screen and were thus less cognitively impaired at Wave 3 than subjects 
101 
 
  
for whom I used Wave 3 data. This may explain why they were still less cognitively 
impaired at Wave 4 than Wave 3 subjects. It was also found that subjects at the Wave 3 
CA visit were more likely to be 85 years of age or older (versus less than 85 years of age) 
than subjects at the Wave 4 CA visit. The may also be due to the method of deciding 
which wave to use; Wave 4 subjects did not pass the cognitive screen and were thus less 
cognitively impaired at Wave 3 than Wave 3 subjects, which implies that they were 
younger at Wave 3 than Wave 3 subjects, young enough that they may have still been 
younger at Wave 4 than Wave 3 subjects at Wave 3. I also found that Wave 4 CA 
informants were more likely to have known the subject for more than 55 years (versus 
less than 55 years), which is logical, given an additional 3 years elapsed between waves. 
In addition, Wave 4 subjects were more likely to use medication with depressogenic side 
effects than Wave 3 subjects. This is surprising, given the previous finding that Wave 4 
subjects were younger than Wave 3 subjects. I also found that Wave 4 CA informants 
were more likely to be less than 65 years of age than Wave 3 CA informants. This may 
be because Wave 4 CA informants were slightly less likely to be spouses than Wave 3 
CA informants (this difference approached significance—χ2 = 3.3, p = .07), and CA 
spouse informants were more likely to be 65 and older than CA non-spouse informants 
(χ2 =510.9, p < .001). I also found that Wave 4 subjects were more likely to be depressed 
on the CA-Self than Wave 3 subjects, and that Wave 3 subjects had a longer elapsed time 
between CA and MD visit than Wave 4 subjects; mean elapsed time was 8.1 months 
(SD = 5.6) for Wave 3 subjects and 6.6 months (SD = 2.9) for Wave 4 subjects (p = .031). 
It is unclear why these results would occur.  
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Mean Imputation Procedure for PHQ-9 
 
If a subject had any missing responses on the CA-Self, I added to the total score 
the mean of the nonmissing responses for each item that was missing, provided that no 
more than four items were missing. This method of mean substitution differs from that in 
which the mean total score of participants with non-missing total scores is imputed as the 
mean total score for participants with missing total scores. The latter method has been 
discredited because it biases scores towards the average (Graham, 2009). In this study, 
the mean of each participant’s non-missing items is imputed as the value for their missing 
items, resulting in a more personally tailored estimate of each participant’s total score. Of 
the 1,481 persons that went to the CA visit, 107 did not complete the CA-Self or were 
missing more than four items, 1,362 completed the entire CA-Self, and 11 completed the 
CA-Self but had four or fewer items missing. Of this latter group, an average of 0.79 
points (range: 0.25 to 1.60) was imputed to each score. This imputation resulted in two 
cases moving from not having major depression to having major depression.  
Analyses were conducted to assess the equivalence on a number of demographic 
characteristics, as well as on cognitive status, across those who did not complete the CA-
Self (or were missing more than four items), those who completed the entire CA-Self, 
and those who completed the CA-Self but had four or fewer items missing, i.e., those that 
received the mean imputation. I used ANOVA to assess equivalence across these 
missingness groups on years of education and subject age at the CA visit. Omnibus 
ANOVA was significant for years of education, F(2,1469) = 3.9, p = .02. Post hoc Tukey 
tests revealed that those who did not complete the CA-Self had significantly fewer years 
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of education (M = 12.9) than those who completed the entire CA-Self (M = 13.7). The 
mean of the mean imputation group (M = 13.5) was similar to the completed group, but 
was not significantly different from the non-completed group, most likely because of low 
cell size. Omnibus ANOVA was also significant for subject age, F(2, 1477) = 22.00, 
p < .001. Similar to years of education, post hoc Tukey tests revealed that the 
noncompleted group was significantly older (M = 86.2) than the completed group (M = 
82.7), with the mean imputation group being equivalent to the completed group (M = 
82.7).  These analyses indicate that participants who received the mean imputation were 
similar to those who completed the entire CA-Self in terms of age and education, and that 
these two groups were different from those that did not complete the CA-Self in terms of 
these factors.  
Table B3 presents results from chi-square analyses that assess equivalence across 
missingness groups on the remaining demographic factors and on cognitive status. 
Ethnicity, marital status, and gender were not significant, indicating that participants in 
the different missingness groups were similar on these factors. The chi square test for 
cognitive status was significant, χ2 (4, n = 1,480) = 60.8, p < .001. Crosstabulations  
 
Table B3 
 
Equivalence Across Missingness Categories on PHQ-9 
Category Chi square p value 
Ethnicity 11.4 0.08 
Marital status 12.2 0.14 
Gender 3.6 0.17 
Cognitive status 60.8 < .0005 
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indicated that those who did not complete the CA-Self (n = 107) were more likely to be 
demented than those who did complete the CA-Self (n = 1,362) and those who received 
the mean imputation (n = 11). This increased likelihood of dementia may explain why 
these subjects could not complete all or some items on this measure, despite being similar 
to subjects who completed the measure in terms of age and education. 
 
Determining Multicollinearity Between Informant Relationship and 
Number of Years the Informant Had Known the Subject 
 
To assess the possibility that the informant relationship with the subject and the 
number of years the informant had known the subject were the same construct, I 
computed Pearson correlations between these factors. Because spouses were coded as “1” 
and nonspouses were coded as “2,” a negative relationship would indicate that spouse 
informants were more likely to have known the subject for longer. This correlations was 
low (CA visit: r = -.221, MD visit: r = -.394), indicating that, although the constructs are 
similar and overlap, they are dissimilar enough to consider them separately as potential 
moderator variables influencing agreement on pairs of depression measures.   
 
Tables Reporting Cell Sizes for Models that Included Moderators 
 
Tables B4-B32 report cell sizes for models that included moderators. 
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Table B4 
 
CA-Self by CA-Informant and Subject Gender 
 
CA-Self 
───────────────────────────   
 
No major depression 
───────────── 
Major depression 
────────────  
CA-Informant n % n % total 
No major depression      
 Male 524  93.4 37 6.6 561 
 Female 673 91.4 63 8.6 736 
Major depression      
 Male 24 82.8 5 17.2 29 
 Female 19 76.0 6 24.0 25 
Total 1,240  111  1,351 
 
 
 
Table B5 
 
CA-Self by CA-Informant and Subject Age 
 
 
CA-Self 
───────────────────────────   
 
No major depression 
───────────── 
Major depression 
────────────  
CA-Informant n % n % total 
No major depression      
 < 85 797 92.7 63 7.3 860 
 85+ 398 91.5 37 8.5 435 
Major depression      
 < 85 29 74.4 10 25.6 39 
 85+ 14 93.3 1 6.7 15 
Total 1,238  101  1,339 
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Table B6 
 
CA-Self by CA-Informant and Dementia 
 
 
CA-Self 
───────────────────────────   
 
No major depression 
───────────── 
Major depression 
────────────  
CA-Informant n % n % total 
No major depression      
 Normal 567 97.3 16 2.7 583 
 MCI/OCI 492 88.0 67 12.0 559 
 Dementia 138 89.0 17 11.0 155 
Major depression      
 Normal 7 77.8 2 22.2 9 
 MCI/OCI 18 85.7 3 14.3 21 
 Dementia 18 75.0 6 25.0 24 
Total 1,240  111 1 1,351 
 
 
 
 
Table B7 
 
CA-Self by CA-Informant and Subject Prior History of Depression 
 
 
CA-Self 
───────────────────────────   
 
No major depression 
───────────── 
Major depression 
────────────  
CA-Informant n % n % total 
No major depression      
 No prior major depression 1,012 94.8 55 5.2 1,067 
 Prior major depression 148 79.1 39 20.9 187 
Major depression      
 No prior major depression 29 85.3 5 14.7 34 
 Prior major depression 12 66.7 6 33.3 18 
Total 1,201  103  1,304 
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Table B8 
 
CA-Self by CA-Informant and Subject Medical Conditions 
 
 
CA-Self 
───────────────────────────   
 
No major depression 
───────────── 
Major depression 
────────────  
CA-Informant n % n % total 
No major depression      
 Had < 2 medical conditions 466 94.9 25 5.1 491 
 Had 2+ medical conditions 731 90.7 75 9.3 806 
Major depression      
 Had < 2 medical conditions 21 91.3 2 8.7 23 
 Had 2+ medical conditions 22 71.0 9 29.0 31 
Total 1,240  111  1,351 
 
 
 
Table B9 
 
CA-Self by CA-Informant and Subject Medication Use 
 
 
CA-Self 
───────────────────────────   
 
No major depression 
───────────── 
Major depression 
────────────  
CA-Informant n % n % total 
No major depression      
 Not taken meds 932 92.9 71 7.1 1,003 
 Taken meds 265 90.1 29 9.9 294 
Major depression      
 Not taken meds. 34 79.1 9 20.9 43 
 Taken meds. 9 81.8 2 18.2 11 
Total 1,240  111  1,351 
 
  
108 
 
  
Table B10 
 
MD-Self by MD-Informant and Subject Gender 
 
 
MD-Self 
───────────────────────────   
 
No major depression 
───────────── 
Major depression 
────────────  
MD-Informant n % n % total 
No major depression      
 Male 35 92.1 3 7.9 38 
 Female 33 66.0 17 34.0 50 
Major depression      
 Male 5 71.4 2 28.6 7 
 Female 4 57.1 3 42.9 7 
Total 77  25  102 
 
 
 
Table B11 
 
MD-Self by MD-Informant and Subject Age 
 
 
MD-Self 
───────────────────────────   
 
No major depression 
───────────── 
Major depression 
────────────  
MD-Informant n % n % total 
No major depression      
 < 85 41 82.0 9 18.0 50 
 85+ 27 71.1 11 28.9 38 
Major depression      
 < 85 7 70.0 3 30.0 10 
 85+ 2 50.0 2 50.0 4 
Total 77  25  102 
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Table B12 
 
MD-Self by MD-Informant and Cognitive Status 
 
MD-Self 
───────────────────────────   
 
No major depression 
───────────── 
Major depression 
────────────  
MD-Informant n % n % total 
No major depression      
 MCI/OCI 44 75.9 14 24.1 58 
 Dementia 18 78.3 5 21.7 23 
Major depression      
 MCI/OCI 3 50.0 3 50.0 6 
 Dementia 5 71.4 2 28.6 7 
Total 70  24  94 
 
 
 
Table B13 
 
MD-Self by MD-Informant and Prior History of Depression 
 
 
MD-Self 
───────────────────────────   
 
No major depression 
───────────── 
Major depression 
────────────  
MD-Informant n % n % total 
No major depression      
 No prior major depression 62 82.7 13 17.3 75 
 Prior major depression 5 50.0 5 50.0 10 
Major depression      
 No prior major depression 6 66.7 3 33.3 9 
 Prior major depression 3 75.0 1 25.0 4 
Total 76  22  98 
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Table B14 
 
MD-Self by MD-Informant and Medical Conditions 
 
 
MD-Self 
───────────────────────────   
 
No major depression 
───────────── 
Major depression 
────────────  
MD-Informant n % n % total 
No major depression      
 Had < 2 medical conditions 24 77.4 7 22.6 31 
 Had 2+ medical conditions 44 77.2 13 22.8 57 
Major depression      
 Had < 2 medical conditions 3 50.0 3 50.0 6 
 Had 2+ medical conditions 6 75.0 2 25.0 8 
Total 77  25  102 
 
 
 
 
 
Table B15 
 
MD-Self by MD-Informant and Medications 
 
 
MD-Self 
───────────────────────────   
 
No major depression 
───────────── 
Major depression 
────────────  
MD-Informant n % n % total 
No major depression      
 Not taken meds. 55 78.6 15 21.4 70 
 Taken meds. 13 72.2 5 27.8 18 
Major depression      
 Not taken meds. 7 63.6 4 36.4 11 
 Taken meds. 2 66.7 1 33.3 3 
Total 77  25  102 
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Table B16 
 
MD-Doc by MD-Self and Gender 
  
 
MD-Doc 
───────────────────────────   
 
No major depression 
───────────── 
Major depression 
────────────  
MD-Self n % n % total 
No major depression      
 Male 44 95.7 2 4.3 46 
 Female 55 94.8 3 5.2 58 
Major depression      
 Male 5 71.4 2 28.6 7 
 Female 23 92.0 2 8.0 25 
Total 127  9  136 
 
 
 
Table B17 
 
MD-Doc by MD-Self and Subject Age 
 
 
MD-Doc 
───────────────────────────   
 
No major depression 
───────────── 
Major depression 
────────────  
MD-Self n % MD-Self n % 
No major depression      
 < 85 58 92.1 5 7.9 63 
 85+ 41 100.0 0 0.0 41 
Major depression      
 < 85 11 78.6 3 21.4 14 
 85+ 17 94.4 1 5.6 18 
Total 127  9  136 
 
  
112 
 
  
Table B18 
 
MD-Doc by MD-Self and Dementia Status 
 
 
MD-Doc 
───────────────────────────   
 
No major depression 
───────────── 
Major depression 
────────────  
MD-Self n % MD-Self n % 
No major depression      
 MCI/OCI 63 95.5 3 4.5 66 
 Dementia 27 93.1 2 6.9 29 
Major depression      
 MCI/OCI 19 86.4 3 13.6 22 
 Dementia 8 88.9 1 11.1 9 
Total 127  9  136 
 
 
 
 
Table B19 
 
MD-Doc by MD-Self and Prior History of Depression 
 
 
MD-Doc 
───────────────────────────   
 
No major depression 
───────────── 
Major depression 
────────────  
MD-Self n % n % total 
No major depression      
 No prior major depression 86 96.6 3 3.4 89 
 Prior major depression 11 84.6 2 15.4 13 
Major depression      
 No prior major depression 19 90.5 2 9.5 21 
 Prior major depression 7 87.5 1 12.5 8 
Total 123  8  131 
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Table B20 
 
MD-Doc by MD-Self and Medical Conditions 
 
 
MD-Doc 
───────────────────────────   
 
No major depression 
───────────── 
Major depression 
────────────  
MD-Doc n % n % total 
No major depression      
 Had < 2 medical conditions 34 91.9 3 8.1 37 
 Had 2+ medical conditions 65 97.0 2 3.0 67 
Major depression      
 Had < 2 medical conditions 7 85.7 2 14.3 14 
 Had 2+ medical conditions 16 88.9 2 11.1 18 
Total 127  9  136 
 
 
 
 
 
Table B21 
 
MD-Doc by MD-Self and Medications 
 
 
MD-Doc 
───────────────────────────   
 
No major depression 
───────────── 
Major depression 
────────────  
MD-Self n % n % total 
No major depression      
 Not taken meds. 76 96.2 3 3.8 79 
 Taken meds. 23 92.0 2 8.0 25 
Major depression      
 Not taken meds. 22 88.0 3 12.0 25 
 Taken meds. 6 85.7 1 14.3 7 
Total 127  9  136 
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Table B22 
 
MD-Doc by MD-Informant and Gender 
 
 
MD-Doc 
───────────────────────────   
 
No major depression 
───────────── 
Major depression 
────────────  
MD-Informant n % n % total 
No major depression      
 Male 44 95.2 2 4.8 42 
 Female 49 96.1 2 3.9 51 
Major depression      
 Male 4 57.1 3 42.9 7 
 Female 6 75.0 2 25.0 8 
Total 99  9  108 
 
 
 
 
Table B23 
 
MD-Doc by MD-Informant and Subject Age 
 
 
MD-Doc 
───────────────────────────   
 
No major depression 
───────────── 
Major depression 
────────────  
MD-Informant n % MD-Self n % 
No major depression      
 < 85 49 92.5 4 7.5 53 
 85+ 40 100.0 0 0.0 40 
Major depression      
 < 85 6 60.0 4 40.0 10 
 85+ 4 80.0 1 20.0 5 
Total 99  9  108 
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Table B24 
 
MD-Doc by MD-Informant and Cognitive Status 
 
 
MD-Doc 
───────────────────────────   
 
No major depression 
───────────── 
Major depression 
────────────  
MD-Informant n % MD-Self n % 
No major depression      
 MCI/OCI 59 95.2 3 4.8 62 
 Dementia 23 95.8 1 4.2 24 
Major depression      
 MCI/OCI 3 50.0 3 50.0 6 
 Dementia 5 71.4 2 28.6 7 
Total 90  9  99 
 
 
 
Table B25 
 
MD-Doc by MD-Informant and Prior History of Depression 
 
 
MD-Doc 
───────────────────────────   
 
No major depression 
───────────── 
Major depression 
────────────  
MD-Informant n % n % total 
No major depression      
 No prior major depression 76 95.0 4 5.0 80 
 Prior major depression 10 100.0 0 0.0 10 
Major depression      
 No prior major depression 8 88.9 1 11.1 9 
 Prior major depression 2 40.0 3 60.0 5 
Total 96  8  104 
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Table B26 
 
MD-Doc by MD-Informant and Medical Conditions 
 
 
MD-Doc 
───────────────────────────   
 
No major depression 
───────────── 
Major depression 
────────────  
MD-Informant n % n % total 
No major depression      
 Had < 2 medical conditions 31 96.9 1 3.1 32 
 Had 2+ medical conditions 58 95.1 3 4.9 61 
Major depression      
 Had < 2 medical conditions 3 50.0 3 50.0 6 
 Had 2+ medical conditions 7 77.8 2 22.2 9 
Total 99  9  108 
 
 
 
Table B27 
 
MD-Doc by MD-Informant and Medications 
 
 
MD-Doc 
───────────────────────────   
 
No major depression 
───────────── 
Major depression 
────────────  
MD-Informant n % n % total 
No major depression      
 Not taken meds. 71 95.9 3 4.1 74 
 Taken meds. 18 94.7 1 5.3 19 
Major depression      
 Not taken meds. 8 72.7 3 27.3 11 
 Taken meds. 1 33.3 2 66.6 3 
Total 98  9  108 
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Table B28 
 
CA-Self by CA-Informant and Informant Relationship 
 
 
CA-Self 
───────────────────────────   
 
No major depression 
───────────── 
Major depression 
────────────  
CA-Informant n % n % total 
No major depression      
 Spouse 555 93.9 36 6.1 591 
 Non-spouse 523 90.2 57 9.8 580 
Major depression      
 Spouse 15 83.3 3 16.7 18 
 Non-spouse 25 75.8 8 24.2 33 
Total 1,118  104  1,222 
 
 
 
Table B29 
 
CA-Self by CA-Informant and Informant Frequency of Contact 
 
 
CA-Self 
───────────────────────────   
 
No major depression 
───────────── 
Major depression 
────────────  
CA-Informant n % n % total 
No major depression      
 Lives with subject 601 92.7 47 7.3 648 
 Not lives subject 416 90.8 42 9.2 458 
Major depression      
 Lives with subject 16 80.0 4 20.0 20 
 Not lives subject 18 72.0 7 28.0 25 
Total 1,051  100  1,151 
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Table B30 
 
CA-Self by CA-Informant and Informant Age 
 
 
CA-Self 
───────────────────────────   
 
No major depression 
───────────── 
Major depression 
────────────  
CA-Informant n % MD-Self n % 
No major depression      
 < 65 years old 197 89.1 24 10.9 221 
 65+ years old 626 93.0 47 7.0 673 
Major depression      
 < 65 years old 11 73.3 4 26.7 15 
 65+ years old 16 88.9 2 11.1 18 
Total 850  77  927 
 
 
 
Table B31 
 
CA-Self by CA-Informant and Informant Gender 
 
 
CA-Self 
───────────────────────────   
 
No major depression 
───────────── 
Major depression 
────────────  
CA-Informant n % MD-Self n % 
No major depression      
 Male 329 91.1 32 8.9 361 
 Female 752 92.5 61 7.5 813 
Major depression      
 Male 3 100.0 0 0.0 3 
 Female 37 77.1 11 22.9 48 
Total 1,121  104  1,225 
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Table B32 
 
CA-Self by CA-Informant and Number of Years the Informant Had Known Subject 
 
 
CA-Self 
───────────────────────────   
 
No major depression 
───────────── 
Major depression 
────────────  
CA-Informant n % MD-Self n % 
No major depression      
 < 55 years old 427 91.0 42 9.0 469 
 55+ years old 454 91.5 42 8.5 496 
Major depression      
 < 55 years old 24 75.0 8 25.0 32 
 55+ years old 6 85.7 1 14.3 7 
Total 911  93  1,004 
 
 
